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Abstract 
 
Murine embryonic stem cells are cells that are obtained from the inner cell mass of the 
embryo blastocyst  at day 3.5. These cells have the novel capability of differentiating into 
almost any cell lineage in the mammal and this characteristic has resulted in them being 
referred to as pluripotent.  
 
 
Fibronectin is involved in a number of different functions including differentiation, 
growth, migration and the adhesion of cells. In addition it is well known to interact with 
the extracellular matrix. Fibronectin also has an essential role to play in early development 
of the embryo as studies have shown that knocking out either fibronectin or its primary 
receptor eg α5β1 integrin receptor is lethal to the developing embryo. 
 
 
The section of fibronectin identified as being essential for binding and activation of α5β1 
integrin receptor has been identified as the 9
th and 10
th type III fibronectin domain. This 
peptide of fibronectin has subsequently been generated. In this study, the effect of this 
fibronectin peptide on murine embryonic stem cells was examined. In particular it was 
identified that the generation of 2-D orientated fibronectin peptide displays in no way 
enhances the cell attachment potential of the fibronectin peptides. The optimal 
conformation of the peptides for the attachment of embryonic stem cell colonies was 
identified as being the dimeric form of the peptide. The fact that these fibronectin peptides 
have no effect on the proliferation of embryonic stem cells was also determined.  
 
 
There was an apparent morphological change in embryonic stem cells grown on the 
fibronectin peptides. These embryonic stem cells were flatter and reminiscent of 
differentiated embryonic stem cells. This occurred even when the embryonic stem cells 
were cultured in the presence of LIF, the cytokine essential to maintain embryonic stem 
cells in a state of self renewal. Alkaline phosphatase staining confirmed that while there 
was a morphological change the embryonic stem cells maintained their undifferentiated 
state when grown on fibronectin peptides in the presence of LIF. Finally Quantitative   3 
Polymerase Chain Reaction was carried out in an attempt to ascertain why there appeared 
to be a morphological change in embryonic stem cells grown on fibronectin peptides as 
opposed to embryonic stem cells grown on gelatin controls. In the presence of LIF, there 
was a transient increase in the number of Oct-4, Brachyury and Nestin transcripts. Up 
regulation of these genes is known in some cases to come from a pro differentiation signal. 
However concomitant with these transcriptional up regulations, the levels of Nanog, the 
gene well known to resist and/or reverse changes in gene expression states in embryonic 
stem cells also increased upon growth on fibronectin peptides.  
 
 
It is possible that in the presence of LIF, Nanog increases to inhibit the differentiation 
inducing signals produced by interaction of the fibronectin peptides with the α5β1 integrin 
receptor. When grown in complete media containing foetal calf serum in the absence of 
LIF, there were no obvious transcriptional changes that gave an indication to which, if any, 
lineage the fibroenctin peptides may be instructing the embryonic stem cells to 
differentiate into.  
 
 
Upon using serum replacement media as opposed to foetal calf serum and allowing the 
embryonic stem cells to differentiate more obvious transcriptional changes were observed. 
ES cells grown on the fibronectin peptides appeared to be inhibited from increasing the 
levels of transcripts with known roles in cardiac and neuroectodermal differentiation. 
However there was a transient increase in the levels of FoxA2, a gene involved in the 
differentiation of embryonic stem cells into endodermal tissue. This increase was shortly 
followed by a significant decrease in the levels of transcripts when grown on the 
fibronectin peptides as opposed to gelatin controls.  
 
 
Importantly it appears that allowing the differentiation of embryonic stem cells to occur in 
a monolayer instead of the classically used embryoid bodies could potentially be used as 
an alternative model to study embryonic stem cell differentiation.  
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ECM        Extracellular matrix 
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FIII8        8
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FIII10        10
th type III fibronectin domain 
FIII9-FIII10      peptide composed of the 9
th and 10
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FAK        Focal adhesion kinase 
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Fgf5        Fibroblast growth factor 5 
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Gly (G)      Glycine 
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IL-6        Interleukin-6 
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Klf4        Kruppel-like family of transcription factor 4 
KO        Knockout 
LIF        Leukaemia inhibitory factor 
LIFR        Leukaemia inhibitory factor receptor 
MEFs        Mouse embryonic fibroblasts 
MEM        Non essential amino acids 
ml        Millilitre 
µl        Microlitre 
mM        Millimolar 
mRNA       messenger ribonucleic acid 
n        number of samples 
NaCl        Sodium chloride 
Na2HPO4      Sodium hydrogen phosphate 
NFκB        Nuclear factor kappa-light-chain-enhancer of activated B 
cells 
NTC        Non template control 
O.D.        Optical density 
OSM        Oncostatin-M 
PBS        Phosphate buffered saline 
PCR        Polymerase chain reaction 
PHAAA      Mutated pentapeptide of the FIII9 domain 
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Pro (P)       Proline   13 
QPCR       Quantitative polymerase chain reaction 
Leu (L)      Leucine 
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RNA        Ribonucleic acid 
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Ser (S)       Serine 
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Th17        T helper 17 cells 
TTP        Tail tip fibroblasts  
U/ml        Units per millilitre 
Undiff control     Undifferentiated ES cell control 
VKNEED      hexapeptide of the FIII8 domain 
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Chapter 1 Introduction 
1.1. The identification of embryonic stem cells 
 
Embryonic stem (ES) cells are continually growing cells derived from the blastocyst of the 
developing embryo that have the ability to generate all three of the primary germ layers ie 
the  mesoderm,  endoderm  and  ectoderm.  (Smith  2001,  Murry  et  al  2008).  Under  the 
appropriate culture conditions ES cells can undergo self renewal and maintain their full 
differentiation capacity through prolonged in vitro culture. (Smith 2001, Murry et al 2008). 
Despite their ability to differentiate into all 3 of the germ layers, as ES cells on their own 
are unable to result in the generation of a blastocyst and cannot differentiate into certain 
cell  lineages  such  as  the  trophoectoderm  under  normal  conditions,  ES  cells  are  best 
described as a pluripotent cell lineage, meaning they have the capacity to differentiate into 
a wide range of, but not all cell types. (Smith 2001).   
 
 
The derivation of ES cells was first reported in 1981 (Evans et al 1981, Martin et al 1981) 
when it was shown that ES cells could be obtained from the inner cell mass (ICM) of the 
developing embryo (Evans et al 1981, Martin et al 1981). Kaufman and colleagues (Evans 
et al 1981) overcame the difficulty of isolating the epiblast through the induction of a 
phase in the developing embryo known as diapause, which occurs before the blastocyst 
implants itself into the uterine wall (Smith 2001). Though diapause is a physiologically 
normal process in rodents it can be enforced through the ovariectomisation of pregnant 
mice  (Smith  2001).  This  delay  in  implantation  enabled  Evans  et  al  1981  to  obtain 
blastocysts from the pregnant mice. Martin et al 1981 identified that ES cells obtained 
from  the  ICM  could  be  maintained  in  an  undifferentiated  state  when  co-cultured  with 
feeder cells. The reason for the effective culturing of ES cells with feeder layers was then 
identified as the actions of a cytokine produced by the feeder cells, namely Leukaemia 
Inhibitory Factor (LIF) (Smith et al 1988, Williams et al 1988) as discussed later.  
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1.2. Generation of mice chimeras from embryonic stem cells 
 
The most useful characteristic of ES cells in terms of scientific research is the ability to use 
these cells to generate genetically manipulated mice designed to look at the specific role(s) 
that any one or multiple genes play in the life  of a mammal. Generation of so called 
“knockout models” can often provide an insight into the function a gene can play in a 
range of contexts. An example of this within our own lab was the generation of mice 
deficient  in  the  atypical  chemokine  receptor  D6  that  identified  the  role  of  D6  in  the 
resolution of inflammation in a model of psoriasis (Jaimeson et al 2005). Today the use of 
ES cell generated mice is a standard method to test an in vitro hypothesis in an animal 
model that provides a more physiologically relevant insight into the particular aspect one is 
investigating. If ES cells are cultured appropriately, they maintain the ability to re-integrate 
into the developing embryo and generate genetically manipulated mice.(Smith 2001)  
 
 
The initial study that identified the ability of ES cells to produce genetically altered mice 
was  first  published  in  1984  (Bradley  et  al  1984).  This  study  examined  the  ability  of 
pluripotent  cells,  derived  from  the  fertilized  embryo,  to  generate  germ-line  chimeras. 
Through  use  of  blastocyst  injection  Robertson  and  colleagues  (Bradley  et  al  1984) 
demonstrated the ability of ES cells derived from fertilized embryos to contribute to the 
generation of live mice with no apparent developmental defects. ES cells injected into 
blastocysts was then investigated in order to identify which tissues in particular ES cells 
contributed to (Beddington et al 1989). This study subsequently showed that injected ES 
cells tended to contribute to the formation of the extraembryonic mesoderm and the foetus. 
ES cells were also capable of inducing the formation of the parietal or visceral endoderm . 
(Beddington et al 1989). This study concluded that ES cells were reminiscent of the ICM 
(Beddington et al 1989), which is the current view held today.  
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1.3. Roles of external factors in the control of ES cell pluripotency 
 
One of the more remarkable properties of ES cells is their ability to be maintained as a 
homogeneous population that is undifferentiated even during sustained culturing (Smith 
2001). Providing they are cultured under controlled conditions ES cells can be expanded 
indefinitely while maintaining their pluripotent characteristics (Smith 2001). It should be 
noted however that the ability of ES cell populations to remain in an undifferentiated state 
in long term culture is not a natural property of these cells. ES cells require to be grown in 
media  containing  specific  nutrients,  metabolites  and  polypeptides  to  ensure  a 
homogeneous, pluripotent population (reviewed in Smith 2001). In vivo the appearance of 
cells with ES cell properties is only transient so it is perhaps not  surprising that cells 
derived from this pluripotent population require a certain level of manipulation in order for 
them to remain in an undifferentiated state (reviewed in Smith 2001). 
 
 
 In the 1970s pioneering EC cell biologists observed the necessity of culturing EC cells on 
feeder layers of growth arrested embryonic fibroblasts (Martins and Evans 1975). It was 
several years later that this initial premise was shown to be only partially correct.  
 
 
In 1988 a landmark discovery was made as it was identified that the cytokine Leukaemia 
Inhibitory Factor (LIF) was capable of maintaining ES cells in an undifferentiated state 
(Smith et al 1988, Williams et al 1988). Smith et al 1988 used biochemical purification to 
identify that LIF was the agent from Buffalo rat liver (BRL) conditioned media responsible 
for the ES cells retaining their pluripotent state after long term culture. The conditioned 
medium was then purified to obtain LIF that was found to have a molecular weight of 
20,000kDa (Smith et al 1988), which was in agreement with another group that had cloned 
LIF (Moreau et al 1988). Williams et al 1988 complemented this study by looking for the 
presence of LIF receptors on the surface of ES cells. After noting the presence of LIF 
receptors on the ES cell surface this group then confirmed the ability of recombinant LIF 
to maintain ES cells in a state of self-renewal (Williams et al 1988). They subsequently 
observed  that  at  concentrations  of  LIF  between  1,000-5,000  units/ml  ES  cells  could   17 
maintain their undifferentiated phenotype (Williams et al 1988). Both human and mouse 
LIF were tested and both gave similar results. Concentrations of LIF below 1,000U/ml 
however  resulted  in  a  reduced  number  of  undifferentiated  colonies.  This  paper  further 
showed  that  ES  cells  maintained  long  term  in  the  presence  of  LIF  still  retained  their 
developmental potential (Williams et al 1988).  
 
 
Further  investigation  into  the  ability  of  feeder  cells  to  maintain  an  ES  cell’s 
undifferentiated state led to the discovery that LIF is produced by feeder cells in both a 
diffusible and an extracellular matrix associated form (Rathjen et al 1990). The two forms 
of LIF are encoded by alternative transcripts that produce active proteins with distinct 
biological  functions.  Interestingly  the  majority  of  LIF  was  localised  within  the 
extracellular  matrix.  It  appears  that  ES  cells  grown  on  feeders  would  stimulate  the 
production of diffusible LIF into the medium while in contact with the extracellular matrix 
associated form of LIF (Rathjen et al 1990). 
 
 
The role of LIF in vivo was subsequently identified as a requirement in order for the 
implantation of the blastocyst to occur (Stewart et al 1992). LIF deficient embryos were 
produced  through  the  generation  of  LIF  knockout  ES  cells.  (Stewart  et  al  1992).  The 
subsequent  protein  produced  was  non  functional  as  feeder  cells  produced  from  these 
embryos failed to maintain ES cells in an undifferentiated state (Stewart et al 1992). Mice 
generated from these LIF deficient embryos were reduced in weight in comparison to their 
wild type counterparts and the female LIF deficient mice were unable to implant (Stewart 
et al 1992). This paper then observed that while the embryos developed to the blastocyst 
stage  LIF  produced  by  the  uterine  endometrial  glands  was  a  requirement  in  order  for 
blastocyst implantation to occur (Stewart et al 1992). 
 
 
With the essential role for LIF in ES cell propagation in vitro, and the physiological role in 
vivo determined, steps were then taken to examine whether other factors could promote ES 
cell  self-renewal.  In  1994  Yoshida  et  al  identified  that  Oncostatin-M  (OSM),  Ciliary 
Neurotrophic  Factor  (CNTF)  or  Interleukin-6  (IL-6)  in  combination  with  soluble  IL-6 
receptor could inhibit ES cell differentiation. All these cytokines signal through gp130   18 
therefore gp130 was deemed to be essential for ES cell self-renewal. Through use of gp130 
receptor  deficient  mice  a  role  for  this  receptor  in  the  development  of  embryos  was 
observed as this mutation was lethal at about day 12.5 postcoitum (Yoshida et al 1996). In 
particular  serious  myocardial  and  haemopoietic  defects  were  observed  (Yoshida  et  al 
1996). The function of gp130 signalling in the context of ES cells was further clarified by 
the finding that gp130 KO embryos cannot continue development after diapause. Gp130 
signalling was subsequently found to be required for maintenance of the epiblast (Nichols 
et al 2001). In parallel to this work a series of studies identified that LIF mediated its 
effects on ES cells through the LIF receptor complex (Gearing et al 1991, Gearing et al 
1992, Davis et al 1993). In addition to these studies potential transcription factor(s) were 
being examined. In due course it was revealed that the latent transcription factor, Signal 
transducer and activator of transcription 3 (STAT3) was required for ES cell self renewal 
(Niwa  et  al  1998,  Matsuda  et  al  1999).  To  delineate  the  role  STAT3  has  on  ES  cell 
function one study made use of supertransfection to transfect ES cells with a dominant 
negative  STAT3  (STAT3F)  (Niwa  et  al  1998).  These  transfected  ES  cells  were 
morphologically very similar to differentiated ES cells grown in the absence of LIF (Niwa 
et al 1998). The role of STAT3 on ES cell self renewal was confirmed by the production of 
a  conditionally  active  STAT3  fusion  protein  (STAT3ER)  (Matsuda  et  al  1999).  Upon 
stable transfection of STAT3ER into ES cells it was observed that even in the absence of 
LIF these ES cells could be maintained in an undifferentiated state (Matsuda et al 1999). 
Therefore STAT3 was shown to be an essential transcription factor for the maintenance of 
ES  cells  in  a  state  of  self  renewal.  It  is  interesting  that  STAT3  is  involved  in  the 
maintenance of ES cell self renewal as it is tends to be involved in the differentiation of a 
variety of cell types. One such example of STAT3’s role in the differentiation of cells is its 
role in the much hyped, much publicised, new subset of CD4+ T-cells commonly known 
as Th17s (Stepkowski et al 2008). 
 
 
1.4. Roles of specific genes in the control of ES cell pluripotency 
 
Although there are extrinsic components essential for the maintenance of ES cell self-
renewal, several genes have been identified as playing a major role in the maintenance of 
ES cells in an undifferentiated state. Arguably the most fundamentally important of these 
is Oct-4. Oct-4 is a member of the POU transcription factor family and is essential for the   19 
maintenance of ES cell pluripotency (Nichols et al 1998). Oct-4 functions by interacting 
with the 8 base pair sequence ATGCAAAT, hence Oct meaning octamer (Smith et al 
2001). 
 
 
The role of Oct-4 in ES cells was first identified in 1990. Rosner et al 1990 cloned Oct-4 
then tested its ability to function as a transcription factor. This paper showed that mRNA 
synthesis was upregulated by Oct-4 if stimulated appropriately. Oct-4 mRNA expression 
was  detected  in  undifferentiated  ES  cells  but  importantly  found  to  be  lacking  in 
differentiated ES cells (Rosner et al 1990). Oct-4 was then observed to be present in the 
ICM  and  trophoectoderm,  though  at  much  lower  levels  at  3.5  days  post  coitum  (dpc) 
(Rosner et al 1990). Oct-4 mRNA expression in the trophoectoderm was undetectable at 
4.5 dpc (Rosner et al 1990). In contrast, mRNA expression of Oct-4 in cells not derived 
from  the  trophoectodermal  lineage  maintained  their  expression  of  Oct-4. (Rosner  et  al 
1990).  This  was  clear  evidence  of  differing  spatial  distribution  of  Oct-4  expression 
indicating a specific role in embryo development (Rosner et al 1990). Most importantly 
this paper noted that all early embryo cells expressing Oct-4 maintained pluripotency, a 
feature not found in differentiated ES cells (Rosner et al 1990).  
 
 
These initial studies were taken a step further through use of Oct-4 specific antibodies 
(Palmieri  et  al  1994).  This  showed  that  Oct-4  protein  expression  is  found  in 
undifferentiated ES cells but not in retinoic acid induced differentiated ES cells. ES cells 
induced to differentiate by the removal of LIF also showed substantially reduced Oct-4 
protein expression compared to undifferentiated ES cells. This was the first evidence that 
differences found in Oct-4 mRNA expression had consequences for ES cells in terms of 
functional  protein  levels.  This  was  also  the  first  report  to  observe  that  Oct-4  protein 
expression  increased  in  the  primitive  endoderm,  and  markedly  reduced  upon 
trophoectodermal lineage differentiation. This report was an early indication that Oct-4 had 
a  role  to  play  in  the  lineage  commitment  of  ES  cells  (Palmieri  et  al  1994).  This  was 
subsequently confirmed by Nichols et al 1998 as discussed below. 
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The evidence suggesting a role for Oct-4 in ES cell pluripotency was firmly established by 
a comprehensive report involving the use of Oct-4 deficient ES cells (Nichols et al 1998). 
Oct-4  deficient  embryos  were  unable  to  produce  pups,  suggesting  a  role  for  Oct-4  in 
development.  In  vitro  growth  of  Oct-4  deficient  ES  cells  resulted  in  a  population  of 
trophoblast cells with a complete absence of any discernable ICM (Nichols et al 1998). As 
ES cell lines are obtained from the ICM of the blastocyst this was strong evidence that 
Oct-4 was essential in order to maintain an ES cell’s pluripotent status.  
 
 
Shortly after this breakthrough the same group confirmed initial evidence from Palmieri et 
al 1994 that Oct-4 is closely involved in determining lineage commitment of ES cells 
(Niwa et al 2000). If Oct-4 expression levels increased or decreased by up to 0.5 fold of 
normal  expression  levels,  self-renewal  would  be  maintained.  However  if  Oct-4  levels 
increased between 0.5 fold to just under 2 fold, the ES differentiated into an endodermal 
and mesodermal population (Niwa et al 2000). Finally if Oct-4 protein levels decreased by 
more than 50% of normal a trophoectodermal population was formed. Niwa et al 2000 also 
provided evidence that the self-renewal properties of LIF were not linked to Oct-4 as ES 
cells with enforced Oct-4 expression still differentiated in the absence of LIF (Niwa et al 
2000). The exact molecular mechanisms of Oct-4 in ES cells was further clarified by the 
finding that both the POU DNA binding domain and either the C-terminal or N-terminal 
transactivation domains are required to maintain ES cell self renewal (Niwa et al 2002). 
Mutation of both transactivation domains or the POU DNA binding domain resulted in 
differentiated  ES  cell  colonies.  This  paper  concluded  that  the  transactivation  domain’s 
proline rich properties in conjunction with Oct-4’s POU DNA binding domain were both 
required for ES cell self renewal to be maintained (Niwa et al 2002). 
 
 
In recent years a second intrinsic factor required to maintain ES cell self-renewal was 
identified and referred to as Nanog (Chambers et al 2003, Mitsui et al 2003). It is similar to 
Oct-4 in that this gene codes for a protein which contains a homeodomain. Nanog however 
is classed as a divergent homeodomain protein as it differs substantially from other well 
known homeodomain proteins.(Chambers and Smith 2004). It was observed that Nanog 
was expressed in ES cells but was lacking in other cell lines including hematopoietic, 
fibroblast and parietal endoderm (Chambers et al 2003). This was a clear indication that   21 
whatever  Nanog’s  function,  it  was  confined  to pluripotent  cells.  Indeed,  upon ES  cell 
differentiation the levels of Nanog mRNA dropped significantly (Chambers et al 2003). 
This  finding  was  the  first  evidence  that  Nanog  may  have  a  role  in  maintaining  the 
undifferentiated state of ES cells. 
 
 
 As Nanog appeared to have a role in maintaining ES cell pluripotency the relationship 
between Nanog and LIF mediated gp130 signalling was examined (Chambers et al 2003, 
Mitsui et al 2003). ES cells overexpressing Nanog were grown in the absence of LIF and 
examined for evidence of differentiation. It was observed that in the absence of LIF ES 
cells induced to constitutively express Nanog could maintain their pluripotent state as the 
ES cells maintained their characteristic undifferentiated morphology and did not flatten out 
as is common during ES cell differentiation (Chambers et al 2003, Mitsui et al 2003). Even 
after  sustained  passaging  the  ES  cells  maintained  their  undifferentiated  state.  When 
induced  to  differentiate  through  use  of  chemical  inducers  such  as  retinoic  acid  it  was 
observed that nanog overexpressing ES cells were largely resistant to differentation and 
maintained ES cell pluripotency (Chambers et al 2003). Wildtype ES cells cultured with 
the same inducers differentiated extensively in a matter of days. (Chambers et al 2003). 
However it must be remembered that in wild type ES cells Nanog on its own is not able to 
prevent  ES  cell  differentiation  in  the  absence  of  LIF.  Nanog  must  be  constitutively 
expressed in order for LIF impendent suppression of ES cell differentiation to occur. This 
fact must be taken into account before making any judgement about the possible role(s) of 
Nanog. It was also observed that the activation of STAT3 was unaltered during passaging 
indicating that Nanog could prevent ES cell differentiation by a pathway that was not 
reliant on LIF mediated-gp130 signalling (Chambers et al 2003, Mitsui et al 2003).  
 
 
To gain further insights into the apparent role of Nanog in the pluripotency of ES cells 
Nanog deficient ES cells were generated (Mitsui et al 2003). Upon disruption of Nanog the 
levels  of  Oct-4  and  rex1(another  pluripotency  marker  but  not  discussed  further)  were 
significantly lower compared to wild type ES cells. In addition Nanog deficient ES cells 
were  observed  to  upregulate  several  endodermal  markers  including  both  visceral  and 
parietal  endodermal  markers  as  well  as  endodermal  transcription  factors  (Mitsui  et  al 
2003). These data were clear evidence that Nanog had a role in maintaining ES cell self-  22 
renewal and preventing unrestricted differentiation into endodermal tissues (Mitsui et al 
2003). The generation of Nanog null embryos gave an indication of the in vivo role for 
Nanog (Mitsui et al 2003). These Nanog null embryos lacked any discernable epiblast and 
the ICM obtained from these embryos was unable to remain in an undifferentiated state 
and very quickly differentiated into endodermal tissue (Mitsui et al 2003).  
 
 
From these initial studies (Chambers et al 2003, Mitsui et al 2003) it was clear that Nanog 
is a vital intrinsic factor required to maintain the pluripotency of ES cells. It is interesting 
when one considers the functions of Oct-4 and Nanog as both have differing phenotypes 
when overexpressed or when their function is disrupted.  Overexpression of Oct-4 results 
in  endodermal/mesodermal  differentiation  (Niwa  et  al  2000)  whereas  constitutive 
expression of Nanog results in LIF-independent ES cell self-renewal (Chambers et al 2003, 
Mitsui  et  al  2003).    It  may  be  that  a  function  of  Nanog  is  to  counteract  the  pro-
differentiation  properties  associated  with  increased  levels  of  Oct-4.  If  Oct-4  gene 
expression is disrupted then ES cells will differentiate into trophoectodermal cells (Niwa et 
al  2000)  in  contrast  to  Nanog  null  cells  that  will  form  an  endodermal  population 
(Chambers et al 2003, Mitsui et al 2003). The effects of Oct-4 and Nanog in addition to 
LIF mediated signaling are detailed in figure 1.1. below 
 
 
 
 
 
 
 
 
 
  
 
Figure 1.1. Signalling mechanisms of ES cell self renewal. Expression of Oct-4 and Nanog ensures ES cell 
pluripotency  is  maintained.  In  addition,  BMP  in  combination  with  LIF  act  together  to  inhibit  ES  cell 
differentiation.  BMPs  induces  the  production  of  Id’s  to  inhibit  neural  differentiation.  LIF  prevents  non- 
neural differentiation through activation of STAT3. (Chambers and Smith 2004)   23 
  
It  is  clear  therefore  that  both  transcription  factors  are  required  to  inhibit  ES  cell 
differentiation into different lineages but they do so independently of each other. It could 
be argued that this adds security to the maintenance of ES cell pluripotency by having 
several mechanisms by which pluripotency is maintained. In terms of a physiological role, 
these  genes  could  aid  in  the  differentiation  of  ES  cells  into  specific  lineages  during 
development.  For  example,  ES  cells  required  to  differentiate  into  a  trophoectodermal 
population of cells would inhibit their expression of Oct-4 thus allowing differentiation 
into this lineage. Similarly ES cells could produce an endodermal population if Nanog 
expression was inactivated. 
 
 
Our understanding of Nanog’s function has recently been updated by the finding that, in 
direct contrast to previous reports (Chambers et al 2003, Mitsui et al 2003), Nanog does 
not appear to be essential in order maintain the pluripotency of ES cells. Upon excision of 
the Nanog gene it was observed that all Nanog-/- cell lines remained undifferentiated as 
shown  by  their  ability  to  form  alkaline  phosphatase  positive  colonies  if  grown  in  the 
presence of LIF (Chambers et al 2007). This is in contrast to previous data suggesting that 
Nanog null embryos lost their pluripotent state (Mitsui et al 2003).  This finding also 
provided  evidence  that  LIF  mediated  ES  cell  self-renewal  is  not  dependent  on  Nanog 
(Chambers et al 2007) which would confirm earlier suspicions that the two mechanisms 
are independent of each other (Chambers and Smith 2004).  This study did note however 
that  upon  differentiation  of  Nanog  null  ES  cells  there  was  an  increase  in  endodermal 
markers eg GATA4 and GATA6 in comparison to wild type ES cells (Chambers et al 
2007). This is evidence to confirm the hypothesis that one function of Nanog is to prevent 
differentiation of ES cells into an endodermal population (Chambers and Smith 2004). 
 
 
This confirmed a potential role for Nanog in the inhibition of endodermal differentiation 
suggested in previous studies (Mitsui et al 2003). It was also shown in this study that 
Nanog was not required for ES cells to be integrated into the epiblast (Chambers et al 
2007). This study concluded by suggesting that Nanog’s main function is to result in germ 
cell production and to try to prevent a loss of pluripotency by downregulation of genes that 
would otherwise cause ES cells to differentiate (Chambers et al 2007). However Austin   24 
Smith and colleagues maintained their view that Nanog was not essential to maintain ES 
cell pluripotency as although ES cells did have a greater tendency to differentiate in the 
absence of Nanog, ES cells could still maintain their undifferentiated state (Chambers et al 
2007). 
 
 
Two papers published this year have given us a greater understanding of the function of 
Nanog by reporting that Nanog must homodimerize in order for ES self-self renewal to be 
maintained (Wang et al, 2008, Mullin 2008 et al). It was identified that a tryptophan rich 
region  of  the  C-terminal  domain  was  essential  for  Nanog  homodimerization  to  occur 
(Wang et al 2008, Mullin et al 2008). It is interesting to consider the requirement for the C-
terminal domain in Nanog function when one considers that Oct-4 can make use of either 
its  C-terminal  or  N-terminal  domain  in  order  to  maintain  its  function  as  discussed 
previously (Niwa et al 2002). It is possible that the function of Nanog is more strictly 
controlled than Oct-4. 
 
 
Although there is much evidence to suggest that Oct-4 and Nanog have differing functions 
in ES cell biology as highlighted by the differing phenotypes of ES cells over expressing or 
deficient for the above genes there is increasing evidence to suggest they may cooperate to 
repress ES cell differentiation (Loh et al 2006, Liang et al 2008). Through use of a variety 
of screening techniques it was suggested that Nanog in fact may control the expression 
levels of Oct-4 and Sox2, another marker of pluripotency( Loh et al 2006) and that Oct-4 
and Nanog will bind to one another then form interactions with complexes of repressor 
proteins thus controlling ES cell function ( Liang et al 2008). Additionally Nanog has been 
reported to cooperate with STAT3 to ensure ES cell self-renewal providing a link between 
two pathways that were previously thought to be distinct (Torres et al 2008). This paper 
also  observed  that  Nanog  would  inhibit  NFκB  signalling  which  promotes  ES  cell 
differentiation (Torres et al 2008).  It seems that the multiple mechanisms of ES cell self-
renewal, both intrinsic and extrinsic, may turn out to be more functionally related than first 
thought. Further research into this area will undoubtedly provide more fascinating insights 
into the maintenance of ES cell pluripotency. 
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1.5. Induced pluripotent stem (iPS) cells – A new possibility for ES cells in regenerative 
medicine 
 
As ES cells have the potential to differentiate into almost any cell lineage coded for in the 
mammalian  genome  the  possibility  of  harnessing  this  ability  has  often  being  cited  as 
vindication for the study of human ES cells. Spinal cord injuries, diabetes and parkinson’s 
disease are a few of the human ailments that could be treated through use of human ES 
cells.  However  as  human  ES  cells,  just  like  murine  ES  cells,  are  derived  from  the 
blastocyst of an embryo there have been several moral and ethical objections from leading 
religious  and  political  figures  to  the  use  of  human  embryos  for  any  kind  of  research 
(Jaenisch et al 2004). In addition the recent human-animal hybrid proposal has also been 
met with similar opposition (Karpowicz et al 2004, Hyun et al 2007). Therefore studies 
were carried out in order to determine whether the useful properties of ES cells could be 
generated from other sources.  
 
 
In 2006 it was shown that cells with strikingly similar properties to ES cells could be 
generated from somatically derived cell lines. The initial pioneering study carried out by 
Yamanaka and co-workers provided strong evidence that differentiated cell lines could in 
fact be re-programmed resulting in a reversion to the cell’s previously pluripotent state 
(Takahashi et al 2006). This study carried out an initial screen of potential genes to be used 
in reverting mouse embryonic or adult fibroblast cultures and identified 24 as possible 
factors that could play a role in this.  
 
 
To  identify  which  of  those  genes  could  be  used  to  return  the  above  cell  lines  to  a 
pluripotent  state  a  novel  assay  was  designed.  This  involved  the  insertion  of  a  β-
galactosidase  and  neomycin  resistance  gene  fusion  product  through  homologous 
recombination into a gene expressed in mouse  ES cells but not in differentiated cells, 
Fbx15 (Takahashi et al 2006). These Fbx15-knockin ES cells were found to be unaffected 
even in the presence of high concentrations of G418. However differentiated somatic cells 
derived from Fbx15-knockin cells were unable to survive in standard concentrations of 
G418. This confirmed that only ES cells expressing the above construct could survive in 
G418 conditions. Then through use of retroviral transduction the genes highlighted to have   26 
a  role  in  ES  cell  pluripotency  were  introduced  into  Fbx15-knockin  generated  mouse 
embryonic fibroblasts (MEFs).  
 
 
Upon growth in G418 none of the ES cells with individual genes introduced survived, clear 
evidence that it would take more than one individual gene in order to return the MEFs to 
an ES cell like pluripotent state (Takahashi et al 2006). Upon the retroviral transduction of 
all 24 potential genes colonies that could grow in the presence of G418 were subsequently 
observed. These cells resembled ES cells in terms of expression of ES cell genes and also 
cell doubling times. These initial 24 genes were reduced through individual withdrawal 
trials down to 4 genes deemed essential in order for ES pluripotency to be reactivated 
(Takahashi K et al 2006). These genes were Oct-4, Sox2, Klf4 and c-Myc. Removal of any 
of these retrovirally induced genes resulted in a massive reduction in the number of ES cell 
like colonies observed in the presence of G418 (Takahashi et al 2006).  
 
 
Yamanaka and co-workers (Takahashi et al 2006) then introduced the four genes deemed 
essential for iPS derivation into tail tip fibroblasts (TTP) and again were able to derive 
colonies that could resist G418 conditions. This confirmed that this technique could be 
used on somatic tissues as opposed to embryonic cell lines. These iPS cells were observed 
to have similar though not identical expression levels of genes compared to ES cells and 
were also able to generate mesodermal, endodermal and ectodermal tissue (Takahashi et al 
2006). In addition these iPS cells were found to stain positively for alkaline phosphatase, 
and were also unable to maintain their apparent pluripotent state in the absence of feeder 
cells even in the presence of LIF (Takahashi et al 2006). The last point is interesting and 
highlights a difference between iPS cells and ES cells as ES cells can be maintained in an 
undifferentiated state in the absence of feeders in the presence of LIF (Smith et al 2001). 
Therefore iPS cells appear very similar in many ways to ES cells but it seems that there 
may be subtle differences that must be investigated further. 
 
 
Shortly after the initial publication by Yamanaka and coworkers (Takahashi et al 2006) 
similar studies confirmed their findings that retroviral transduction of Oct-4, c-Myc, Klf4 
and Sox2 could return a somatic cell line such as TTPs to a pluripotent state (Okita et al   27 
2007,  Wernig  et  al  2007).  Both  used  similar  approaches  to  the  initial  publication 
(Takahashi et al 2006) but instead of selecting for Fbx15 these studies used either Nanog 
(Okita et al 2007) or Nanog or Oct-4 ( Wernig et al 2007). These studies (Okita et al 2007, 
Wernig et al 2007) confirmed many of the findings from Yamanaka and coworkers paper 
(Takahashi  et  al  2006)  but  also  highlighted  minor  differences  between  the  iPS  cells 
generated using different protocols. In particular it was noted that use of Nanog to select 
for the iPS cells resulted in the production of iPS cells that could be maintained in an 
undifferentiated state in the presence of LIF even if not co-cultured with feeder cells (Okita 
et al 2007, Wernig et al 2007).  
 
 
This differed from iPS cells selected for using Fbx15 that required both culturing with 
feeder cells and the presence of LIF in the media (Takahashi et al 2006). In one of these 
papers a note of caution was issued regarding the use of iPS cells for regenerative therapies 
due  to  the  possibility  that  use  of  retroviral  transduction  could  inadvertently  lead  to 
upregulation of oncogenes and the onset of cancers (Wernig et al 2007). This study also 
suggested  that  a  greater  understanding  of  the  exact  pathways  of  somatic  cell 
reprogramming  at  the  molecular  level  would  be  advantageous  and  could  lead  to  the 
identification  of  molecules  that  could  reprogram  cells  without  the  need  for  retroviral 
transduction (Wernig et al 2007). 
 
 
The potential uses of iPS cells in treating human disease are obvious, with the possibility 
of generating patient specific tissues that would negate the possibility of immune rejection 
as  is  often  seen  using  conventional  therapies.  Shortly  after  the  discovery  of  iPS  cell 
production using mouse cell lines it was shown by several groups that this could also be 
achieved using human cell lines (Takahashi et al 2007, Yu et al 2007, Park et al 2007, 
Lowry et al 2008). Three of these papers used induced ectopic expression of the four genes 
described previously (Takahashi et al 2006) as being essential for the programming of 
mouse iPS cells in human cell lines including human embryonic fibroblasts (HEFs) and 
adult human dermal fibroblasts (HDF) (Takahashi et al 2007, Park et al 2007, Lowry et al 
2008).  As  in  murine  studies  this  resulted  in  a  reprogramming  of  the  cells  to  a  more 
pluripotent phenotype in terms of their function and morphology. These reprogrammed   28 
cells were subsequently confirmed as human iPS cells through a variety of tests (Takahashi 
et al 2007, Park et al 2007, Lowry et al 2008). 
 
 
The  fourth  paper  published  during  this  initial  phase  of  human  iPS  work  by  James  A 
Thomson  and  colleagues  showed  that  another  combination  of  genes  could  be  used  to 
generate iPS, specifically Oct-4, Sox2, Nanog and LIN28 (Yu et al 2007). The iPS cells 
derived from this process however seemed to fit all the criteria required to be classed as 
iPS cells (Yu et al 2007). One serious problem that could hold back the use of iPS cells in 
regenerative  therapies  was  the  tumour  formation  observed  in  some  mice  through 
reactivation of the c-Myc retrovirus. (Okita et al 2007).  A modified protocol was therefore 
used to generate iPS cells that omitted the use of c-Myc in reprogramming somatic cells 
into  iPS  cells  (Nakagawa  et  al  2008).  The  iPS  cells  generated  displayed  all  the 
characteristics of iPS cells produced through use of the c-Myc retrovirus but did not result 
in tumour formation when used to generate mice. It was noted however that without the c-
Myc retrovirus there was a marked reduction in the ability to generate iPS cells (Nakagawa 
et al 2008). 
The issue of retroviral reactivation may have been solved with the recent report that iPS 
cells could potentially be generated without the use of this technique. In another report 
from Yamanaka and co-workers (Aoi et al 2008) it was shown that the generation of iPS 
cells from liver cells and stomach cells have no requirement for site specific retroviral 
integration. This opens up the possibility that iPS cells could be generated without the use 
of a mechanism now well known to result in the formation of tumours (Aoi et al 2008). iPS 
formation has also been reported through the reprogramming of adult neural stem cells, the 
first publication using an ectodermally derived cell line to do so (Kim et al 2008). This 
study showed that retroviral transduction of Oct-4 and Klf4 was sufficient to generate iPS 
cells from neural stem cells (Kim et al 2008).  This study confirmed the observation of a 
previous report (Nakagawa et al 2008) which observed that iPS cells could be generated 
without the use of the c-Myc retrovirus therefore reducing the chances of spontaneous 
tumor formation (Kim et al 2008).  
 
 
It is clear that iPS cells have the potential to do a great deal for regenerative medicine. 
With iPS cells the moral and ethical issues that come with the use of human ES cells would   29 
largely be avoided. In addition the potential for immunorejection would be addressed as 
iPS cells could be produced from the recipient’s own somatic tissue. It must be noted 
however that although there is much enthusiasm in the scientific community about the 
potential  uses  of  these  cells  this  enthusiasm  must  be  tempered  with  a  measure  of 
scepticism and thorough study to ensure that iPS cells are indeed the exceptionally useful 
cells they appear to be. In particular the possibility of tumorigenicity must be thoroughly 
investigated, if possible a different type of gene transfer system should be used due to the 
possibility of retroviral mediated tumour formation. 
 
1.6. Fibronectin – A multi-functional protein 
 
Fibronectin (FN) is a protein that has several functions in vivo. Of particular importance is 
the role it plays in the development of embryos. Deletion of FN from mouse embryos 
resulted in the death of the embryo clearly demonstrating an essential role in the early 
stages  of  development  (George  et  al  1993).  It  has  also  been  shown  that,  during 
development, embryos upregulate genes involved in the production of FN, therefore they 
have the ability to manufacture FN in a cell autonomous manner (Shirai et al 2005). FN 
tends to be found in a dimeric form in vivo consisting of two subunits of approximately 
250kDa each that are linked via a covalent interaction close to the C-terminus (Pankov and 
Yamanaka 2002). The FN subunits are composed of 12 type I, 2 type II and between 15-17 
type III repeating units. Not only are type III repeating units the most numerous of the 
repeating units they are also the largest being measured at approximately 90 residues each 
(Pankov  and  Yamanaka  2002).  The  type  III  repeating  units  also  lack  any  disufide 
interactions which differs from type I and type II repeating units. Type II repeating units 
contain two intra-chain disulfide bonds and are estimated at 60 amino acids long and type I 
repeating units also contain two disulfide bonds and are believed to be 40 amino acids long 
(Pankov and Yamanaka 2002).  
 
 
 The function of FN is mediated via interactions with members of a family of cell surface 
receptors  known  as  integrins  that  are  described  in  greater  detail  further  on  in  the 
introduction.  In  brief  integrins  are  heterodimeric  receptors  composed  of  two  different 
subunits that are involved in mediating the interaction of the intracellular cytoskeleton with 
the extracellular matrix (ECM) (Hynes 2002). FN can bind to 12 separate integrins and   30 
appears  to  be  the  most  promiscuous  adhesion  molecule  identified  to  date  in  terms  of 
integrin  ligation  (reviewed  in  Plow  et  al  2000).  This  ability  to  interact  with  multiple 
integrins implies that FN is involved in many different interactions in vivo therefore it is 
perhaps  not  surprising  that  disruption  of  the  gene  coding  for  FN  is  embryonic  lethal. 
(Hynes 2002). 
 
 
 Much  study  has  been  done  to  identify  the  sequences  in  FN  essential  for  binding  to 
integrins. The sequence that has received the most attention resides within the 10th type III 
FN (FIII10) domain and is a short sequence of amino acids, Arg-Gly-Asp (RGD). This 
small tripeptide sequence was identified after initial studies into the adhesive properties of 
FN localized the cell binding region of the FN monomers to a specific region of the protein 
(Ruoslahti et al 1981, Ehrismann et al 1982). Peptides were then synthesized spanning the 
region responsible for cell attachment and one area in particular was identified as essential 
in order for cell adhesion to occur (Pierschbacher et al 1983). Further analysis pinpointed a 
sequence  of  four  amino  acids  Arg-Gly-Asp-Ser  as  being  responsible  for  the  adhesive 
properties of FN (Pierschbacher et al 1984). A follow up study revealed that while the 
serine residue was dispensable the ability to adhere cells was lost upon substitution of the 
arginine, glycine or aspartic acid residues (Pierschbacher MD et al 1984). 
 
 
It  was  then  recognized  that  while  the  FIII10  domain  is  essential  for  integrin  binding 
another  sequence,  a  so  called  “synergy”  site,  was  required  for  optimal  binding  to  the 
classical FN receptor α5β1(obara et al 1988, Nagai et al 1991). Although cell adhesion to 
FIII10 could occur it was reduced in comparison to whole FN (Mardon and Grant 1994). 
Soon after these reports the synergy sequence Pro-His-Ser-Arg-Asn(PHSRN) was shown 
to reside on the 9th type III FN domain (FIII9) (Aota et al 1994). This paper made the 
intriguing observation that the amino acid most critical for the function of the synergy site 
was arginine in position 1379 of the sequence. As the RGD sequence on the FIII10 domain 
also contains an arginine it is possible the arginine residues in these positions serve some 
essential role in terms of integrin binding.  
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It was observed in another study that the FIII9 domain did not adhere cells very well and 
required attachment to the FIII10 domain in order to mimic the adhesive properties shown 
by whole FN (Mardon and Grant 1994). In addition, cells grown on FIII10 alone tended to 
be rounder in terms of morphology in contrast to cells grown on FIII9-FIII10 domains that 
had a more spread morphology similar to cells grown on whole FN (Mardon and Grant 
1994). These differences in morphology raised the possibility that the FIII9 and FIII10 
domains carry out distinct functions in cell adhesion. 
 
 
As both the FIII9 and FIII10 domain sequences are found on a loop it was suggested that 
the exact spatial relationship between the FIII9 and FIII10 domains was important in order 
for effective ligation to integrin receptors to occur. This hypothesis was confirmed in 1997 
by a study showing that if the region linking the FIII9 and FIII10 domains was increased 
by  as  little  as  two  amino  acids  the  ability  of  the  FIII9-FIII10  domain  to  induce  cell 
spreading was markedly decreased (Grant et al  1997).  In addition signaling via FAK 
phosphorylation  was  substantially  reduced.  Increasing  the  linker  region  also  led  to  a 
reduction in FIII9-FIII10 domain’s cell adhesion ability but to a lesser extent than cell 
spreading.  This  study  concluded  that  the  exact  structural  conformation  of  FIII9-FIII10 
domain  was  essential  in  order  for  optimal  cell  adhesion/spreading  and  signaling 
mechanisms to occur (Grant et al 1997). Although FIII10 can adhere cells in the absence of 
FIII9, albeit not as efficiently as whole FN, it is clear that for events downstream of the 
initial cell attachment to occur, the spatial relationships between the integrin and FIII9-
FIII10 domain must be precise (Grant et al 1997).   
 
 
Further study of the interaction of FN with the α5β1 integrin receptor led to the finding 
that another sequence could enhance the binding of FN to cells by stabilizing the FIII9 
domain (Altroff et al 2001). The sequence VKNEED on the eighth type III Fn domain 
(FIII8) was identified to be responsible for stabilizing the FIII9 domain. An FIII8-FIII9-
FIII10  peptide  was  shown  to  have  greater  cell  adhesive  and  cell  spreading  properties 
compared with FIII9-FIII10 peptides (Altroff et al 2001). This study also noted that either 
the FIII8 domain on its own or the FIII8 domain attached to the FIII9 domain (FIII8-FIII9) 
had no cell attachment potential demonstrating the necessity of the FIII10 domain for cell 
adhesion to occur (Altroff et al 2001). The FIII8 domain was also shown to restore the   32 
biological activity of FIII9-FIII10 peptides that had their PHSRN sequence mutated to 
PHAAA (Altroff et al 2001). This mutagenesis would otherwise result in a loss of the 
biological  activity  of  the  FIII9-FIII10  peptide  providing  evidence  to  suggest  that  the 
synergy site is only essential when using a FIII9-FIII10 peptide (Altroff et al 2001). 
 
 
One issue that became apparent during the study and design of these FIII9-FIII10 peptides 
was the instability of the FIII9 domain even when attached to the FIII10 domain. In order 
to  investigate  this  matter  further,  a  number  of  different  FIII9-FIII10  domains  were 
constructed  with  mutations  in  their  sequence  to  determine  whether  it  was  possible  to 
enhance  the  stability  of  these  FIII9-FIII10  peptides  (Walle  et  al  2002).  This  study 
determined  that  a  substitution  mutation  of  a  Leucine  residue,  at  position  1408  in  the 
sequence, with a Proline residue improved the stability of the FIII9 domain. It was deduced 
that this mutation inhibited the ability of the FIII9 domain to unfold therefore improving its 
conformational  stability  (Walle  et  al  2002).  It  was  then  ascertained  that  this  mutation 
conferred greater cell adhesion/spreading ability on the FIII9-FIII10 peptides compared to 
wild type FIII9-FIII10 domains (Walle et al 2002). The structure of the FIII9-FIII10 cell 
adhesion domains is shown below. 
 
 
 
 
 
 
 
 
Figure 1.2 Crystal structure of the FIII9-FIII10 adhesive  domain. Personal communication from van der 
Walle and colleagues. 
 
The role of the stability of the FIII9-FIII10 domains in terms of the peptides biological 
functionality  was  dissected  in  more  detail  through  mutation  of  the  synergy  site  in 
conjunction with the leucine to proline mutation at position 1408 (Altroff et al 2003). This 
study first confirmed earlier findings that a leucine to proline mutation at position 1408 in 
the sequence increased the cell adhesion  and cell spreading ability of the FIII9-FIII10 
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peptide compared to wild type FIII9-FIII10 peptides (Walle et al 2002, Altroff et al 2003). 
FIII9-FIII10  domains  with  mutations  in  this  region  quickly  experienced  a  marked 
reduction  in  their  cell  adhesion  potential  and  in  particular  their  cell  spreading  ability 
(Altroff et al 2003). However the ability of these FIII9-FIII10 mutants to promote α5β1 
meditated  cell  adhesion  and  spreading  returned  to  wild  type  levels  upon  mutation  of 
Leucine  to  Proline  at  position  1408  in  the  sequence  highlighting  the  potential  of  this 
mutation to enhance the biological activity of the FIII9-FIII10 domain (Altroff et al 2003). 
The leucine to proline substitution was also shown to stabilize the structure of the FIII9 
domain when mutated in the synergy site (Altroff et al 2003).  
 
 
The advantages of using FIII9-FIII10 peptides with a substitution mutation of leucine 1408 
to  proline  for  cell  attachment  are  clear  and  in  2008  a  study  was  published  by  our 
collaborators using these very peptides (Kreiner et al 2008). This study used the mutant 
FIII9-FIII10 domain described previously (Walle et al 2002) attached to a hinge motif 
taken  from  an  IgG  molecule  and  a  mutated  zipper  derived  from  leucine  amino  acids 
(Kreiner et al 2008). The helices were used to allow the construction of dimeric, trimeric 
and tetrameric peptides to determine the optimal conformation required for cell attachment 
(Kreiner et al 2008).  
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B  
 
Figure 1.3 A. Diagram of  FIII9-FIII10 monomer  B. Schematic representation of 2-D polyvalent display 
utilizing the FIII9-FIII10 subunit. Kreiner et al 2008 and BBSRC grant proposal awarded to van der Walle 
CF, Mardon HJ, Graham GJ 2007. 
 
 
 To allow control over the assembly of the mutant FIII9-FIII10 domains, the chimera’s C-
terminal  cysteine  was  biotinylated  to  ensure  the  chimera’s  became  attached  to  tissue 
culture plastic coated with streptavidin. This resulted in the generation of 2-dimensional 
(2-D) polyvalent displays (Kreiner et al 2008). The peptides generated did not contain the 
FIII8 domain, as although this sequence does provide enhanced cell attachment/spreading 
potential compared with FIII9-FIII10 peptides, it was far harder to generate therefore it 
was more economically sound to use the FIII9-FIII10 peptides as the properties of both 
peptides appear very similar. (Van der Walle personal communication).  
 
 
These studies have shown FN to be a useful protein for cell attachment and cell spreading 
studies. The FIII9-FIII10 peptides used by Van der Walle and co-workers (Kreiner et al 
2008) have shown that this particular sequence of FN is sufficient for the attachment of 
cells expressing the α5β1 integrin receptor. These studies on the precise requirements for 
cell  attachment  are  important  as  they  could  improve  the  efficiency  of  cell  adhesion   35 
therefore use of these peptides could be a more financially sound method of attaching cells 
as opposed to using standard FN.  
 
 
This concludes the discussion of the structural determinants required for FN’s adhesive 
properties. The next section will focus on integrin receptors and their role in mediating the 
effects of FN in the biological context. 
 
 
1.7. Integrins – The mediators of fibronectin function 
 
The effects of adhesion molecules such as FN are mediated through their interaction with 
integrins, a family of cell adhesion receptors (Hynes et al 2002, Humphries et al 2006). 
Integrins are glycoproteins composed of two different subunits, termed α and β subunits 
which are linked via a non covalent interaction. The α and β subunits are composed of 
relatively  small  cytoplasmic  domains  in  comparison  to  their  much  larger  extracellular 
domains  and  both  subunits  are  type  I  transmembrane  proteins  (Hynes  et  al  2002, 
Humphries et al 2006). Currently there are 24 different combinations of the 18 α and 8 β 
subunits that can lead to functional integrin receptors with some subunits such as the αV 
subunit and the β1 subunit appearing in 5 and 12 different integrin receptors respectively 
(Hynes 2002, Humphries et al 2006). Some integrin subunits however, such as the α1 
subunit, are only found in combination with one other specific subunit, in this case the β1 
subunit (Hynes 2002, Humphries et al 2006). Integrins have been known for some time to 
play key roles in a number of different physiological functions such as the movement of 
leukocytes  and  the  development  of  embryos.  In  addition  integrin  receptors  have  been 
linked to the development of cancer and several other human ailments and are also used to 
deliver  anti-inflammatory  drugs  (Hynes  2002).  It  has  also  been  noted  that  integrin 
receptors can be used by a number of bacterial and viral agents in order to gain access to 
the host (Hynes 2002).  
 
 
Due to the number of different roles that integrins can participate in, the focus of the next 
section  will  be  on  integrins  in  the  context  of  cell  attachment  studies,  as  discussed   36 
previously, and their role in developmental biology, as these subject areas most closely 
relate to the project described later in the thesis. 
 
 
In order to investigate the role(s) the α5β1 integrin receptor has in the development of 
embryos, α5 deficient embryos were generated (Yang et al 1993). As α5β1 is one of the 
primary  integrin  receptors  ligated  by  FN  it  should  provide  some  insights  into  the 
importance  of  this  interaction  in  vivo.  The  result  was  that  disruption  of  α5  led  to 
embryonic lethality, suggesting that it played some essential role in the development of 
embryos (Yang et al 1993). Defects in embryo formation were apparent from days 8.5 of 
gestation onwards with death occurring between 10 to 11 days of gestation.  
 
 
In α5 deficient embryos a host of abnormalities were observed such as, neural tube and 
mesodermal  defects,  and  also  extraembryonic  and  vascular  irregularities  indicating  a 
fundamental  role  of  the  α5β1  integrin  receptor  in  development  from  the  8th  day  of 
gestation  onwards  (Yang  et  al  1993).  However  this  study  highlighted  the  functional 
redundancy of integrins as ES cells obtained from α5 null embryos retained the ability to 
migrate  on  FN  (Yang  et  al  1993).  This  was  an  unusual  finding  as  it  was  previously 
believed that this ability was exclusively due to the interaction of FN with α5β1 integrin 
receptor. It could therefore be concluded from this study that, while the integrin α5β1 
plays a key role in the development of embryos, its ability to migrate on FN could be 
carried out by other integrins (Yang et al 1993). These data were early evidence of the now 
well known functional redundancy of certain integrins. In hindsight this may not come as a 
total surprise as there are several examples of receptor families in biology that will mediate 
similar effects through several receptors. A good example of such a receptor family is the 
chemokine receptor family (Rot A and von Adrian 2004). 
This study was complimented by another looking at the effect of inactivating the gene 
encoding FN on embryo development. Just as with α5 deficient embryos the inactivation 
of  FN  resulted  in  early  embryonic  lethality  (George  et  al  1993).  In  another  striking 
similarity to the previously described study (Yang et al 1993), abnormalities in FN null 
embryos were first observed on day 8 of gestation. However substantial embryoid death 
was occurring at this timepoint (George et al 1993, Georges-Labouesse et al 1996). This   37 
accelerated  death  of  the  embryos  upon  deletion  of  FN  showed  that  FN  plays  a  more 
integral role in embryo development than the α5β1 integrin receptor (George et al 1993, 
George Labouesse et al 1996). This was further evidence that integrins other than α5β1 
could be involved in embryo development and that signaling of FN via α5β1 could be 
partially  compensated  with  other  integrins.  α5β1  however  remains  crucial  to  the 
development  of  embryos  due  to  the  observed  embryonic  lethality  upon  α5  deletion 
(George et al 1993). This study also concurred with the observations by Yang et al 1993 in 
that defects in mesodermal development and vasculature and extraembryonic abnormalities 
were  all  observed  (George  et  al  1993).  Interestingly  this  study  observed  that  FN  null 
embryos successfully carried out implantation and began the process of gastrulation but 
noted that irregularities in development were first observable after the onset of gastrulation 
(George et al 1993). 
 
 
 Another study provided strong evidence that FN null embryos die due to the essential role 
that FN plays in the formation of blood vessels and the embryonic heart (George et al 
1997). This observation is compatible with the previous studies (Yang et al 1993, George 
et al 1993) as heart tissue is a mesodermally derived. The subtle roles for various integrins 
capable of binding to FN in embryo development was then extensively dissected through a 
series  of  single  and  double  integrin  gene  inactivations  (Yang  et  al  1999).  It  was 
subsequently  elucidated  that,  in  general,  integrins  that  bind  to  FN  during  embryonic 
development each play a unique, subtle role in the developmental process although there is 
a degree of functional overlap between integrin receptors (Yang et al 1999). The role of the 
FN=α5β1 interaction was further clarified by a study that provided strong evidence that 
the FN binding to α5β1 was essential in order for early angiogenesis and vasculogenesis to 
occur  (Francis  et  al  2002).  These  studies  have  clearly  shown  an essential  role  for  the 
interaction of FN with the α5β1 integrin receptor in early embryo development. Both FN 
and α5β1 integrin receptor appear essential for this process as functional deletion of either 
results in embryonic lethality (Yang et al 1993, George et al 1993). 
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1.8. Project outline 
 
The  purpose  of  this  project  was  to  examine  the  effects  of  the  FIII9-FIII10  domains 
described  in  Kreiner  et  al  2008  on  ES  cell  function  and  morphology.  The  following 
experiments will be carried out in this study, 
 
1. ES cells will be grown in a monolayer on tissue culture plates coated with the FIII9-
FIII10 peptides. In particular the optimal conformation of the FIII9-FIII10 peptides (ie 
monomer, dimer, trimer, tetramer) shall be investigated, then its ability to adhere cells 
compared to whole fibronectin and gelatin controls determined. 
 
2. The ability of the FIII9-FIII10 derivative’s ability to induce ES cell proliferation will be 
examined  by  growing  ES  cells  on  either  the  FIII9-FIII10  derivatives  or  gelatin  then 
counting the number of cells. 
 
3. A LIF titration will be carried out to look at the effects of altering concentrations of LIF 
on the possible effects the FIII9-FIII10 derivatives have on ES cells. 
 
4.The differentiation potential of the FIII9-FIII10 peptides will be examined through use of 
alkaline phosphatase staining, a common marker of undifferentiated ES cells (Jackson et al 
2002).  
 
5.Finally Quantitative Polymerase Chain Reaction (QPCR) will be carried out in order to 
look more closely at any morphological changes that may be occurring with the reasoning 
that if there is a phenotypical change it is possible that the transcript levels may be altered.  
 
This method of investigating the properties of various stimuli on ES cells differs from 
traditional  work  in  that  the ES  cells  will  be  grown  in  a  monolayer  as  opposed  to  the 
generation  of  embryoid  bodies.  There  is  some  evidence  that  ES  cells  can  differentiate 
down a particular lineage upon growth in a 2-D environment (Nishikawa et al 1998, Ying 
et al 2003, Hayashi et al 2007) without the requirement of embryoid body formation. The 
ability to separate out specific precursor lineages using monolayer ES cells gives some 
advantages to this method of ES cell growth over embryoid body formation. There is some   39 
evidence that differentiation into certain lineages is actually more optimal using monolayer 
cultures as opposed to embryoid bodies (Nishikawa 1998). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   40 
Chapter 2 Materials and methods 
 
Tissue culture  
 
 
2.1. Embryonic stem cell culture 
 
ES cell line E14 was cultured in tissue culture flasks in knockout DMEM media to which 
was added 15% ES-tested foetal bovine serum (STEM CELL TECHNOLOGIES), 2mM 
L-glutamine  (Invitrogen),  2mM  penicillin/streptomycin  (Invitrogen),  β-mercaptoethanol 
(SIGMA-ALDRICH), 1000units/ml LIF/ESGRO (CHEMICON INTERNATIONAL), non 
essential amino acids (GIBCO) and gentomycin (SIGMA). These ES cells were split when 
confluency reached approximately 70%. This media is referred to as “complete media” in 
the text. ES cells were fed daily. ES cells allowed to differentiate using serum replacement 
media for QPCR were cultured in media containing; Knockout Serum Replacement for ES 
Cell  Culture  (Invitrogen),  2mM  L-glutamine  (Invitrogen),  2mM  penicillin/streptomycin 
(Invitrogen), β-mercaptoethanol (SIGMA-ALDRICH), non essential amino acids (GIBCO) 
and gentomycin (SIGMA).  ES cells were fed daily. 
 
 
2.2. Coating six-well plates with whole FN or FIII9-FIII10 peptides  
 
The same method was used to coat six-well plates whether whole FN (SIGMA, 0.1% 
solution, from bovine plasma) or FIII9-FIII10 peptides (provided by Van der Walle and 
colleagues,  University  of  Strathclyde)  were  used.  In  brief,  whole  FN  or  FIII9-FIII10 
peptides were diluted to the appropriate concentration required using protein buffer which 
was composed of the following; 300mM NaCl, 10mM Na2HPO4. The protein buffer was 
adjusted  to  pH7,  then  filter  sterilized.  Upon  dilution  of  the  stock  FIII9-FIII10 
derivative/whole FN solution with protein buffer the solution is once again filter sterilized. 
The diluted FIII9-FIII10 peptides/whole FN were then coated onto the six-well plate and 
left to incubate on a shaking platform to allow uniform coating of the plate surface. After 
40  minutes  to  allow  attachment  of  FIII9-FIII10  peptides/whole  FN  the  FIII9-FIII10 
peptide/whole FN was removed from the plate and three 5-minute washes were carried out   41 
using wash buffer (300mM NaCl, 10mM Na2HPO4 , 0.05% tween solution adjusted to 
pH7.8 then filter sterilized). The appropriate number of cells were then seeded and left to 
incubate for the appropriate period of time depending on the desired time point being 
tested. The media in the cultures was changed daily. 
 
 
2.3. Giemsa staining 
 
Giemsa concentrate (BDH Laboratory Supplies) was diluted with water 1 in 10 to obtain a 
10% giemsa solution. Cells to be stained first had their media aspirated following which 
they were washed with PBS. The ES cells were then fixed with methanol (Riedel-de Haen) 
for ten minutes, the fixative removed and the cells allowed to air dry for 30 minutes. 10% 
giemsa stain was then added to the cells and incubated for 10 minutes. The giemsa stain 
was  then  displaced  from  the  ES  cells  by  placing  the  giemsa  stained  cells  under  slow 
running water. After 10 minutes displacement of the giemsa stain the cells were left to dry. 
Once dry the cells were mounted on glass slides. 
 
 
2.4.a Colony counting method 
 
Colonies were counted by taking counts of 10 fields of view of the microscope using a 5x 
magnification.  Care  was  taken  to  avoid  the  peripheral  edges  of  the  plate  as  a 
disproportionate number of colonies are found in this area. (unpublished observations). 
 
 
2.4b Colony counting method-cloning efficiency 
 
Colonies were stained using giemsa after 6 days using protocol 2.3. Then the total numbers 
of colonies were counted by dotting the colonies on the reverse side of the six well plate 
with a marker pen. Cloning efficiency was then calculated using the following equation, 
Number of colonies counted/Number of cells seeded per well x 100. 
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2.5. Alkaline phosphatase staining 
 
Alkaline  phosphatase  (CHEMICON  INTERNATIONAL)  stain  was  carried  out  in 
accordance with instructions included in the kit. Briefly, ES cells were grown on six-well 
plates coated in either gelatin or FN peptide for five days. ES cells were cultured either 
with complete media containing LIF or media with all the constituents required for ES cell 
culture with the exception of LIF. After five days culturing the media was removed and the 
ES cells fixed with 4% paraformaldehyde. Fixative was left on ES cells for no longer than 
1  minute  as  over  fixing  results  in  a  loss  of  alkaline  phosphatase  stain.  Fixative  was 
removed and the ES cells washed with 1x rinse buffer (TBST: 20mM Tris-HCl, pH 7.4, 
0.15M NaCl, 0.05% Tween-20). Alkaline phosphatase stain (constituents provided in kit, 
require to be made up before hand) was then added to the wells, (2ml/well). Wells were 
then incubated in the dark for 10 minutes. Alkaline phosphatase staining solution was then 
removed and ES cells rinsed with 1x rinse buffer. PBS is finally added to prevent the 
stained cells from drying out. Colonies were counted using the method outlined in section 
2.4.a. The percentage of alkaline phosphatase positive and negative ES cells was then 
calculated. 
 
 
2.6. Generation of 2-D polyvalent displays 
 
100µl of avidin (SIGMA) solution (25µg/ml in PBS) was added to each well then left to 
incubate overnight at room temperature. The avidin solution was then aspirated and 3-five 
minute washes with wash buffer carried out. 200µl of 1% Pluronic F108 blocking solution 
(SIGMA) was then added to each well and incubated for two hours at room temperature. 
The Pluronic F108 (SIGMA) was then removed, then washed with wash buffer 3 times for 
five minutes. To create the 2-D displays the FN derivatives were first biotinylated using 
the method outlined in section 2.7. Once the FN derivatives have been biotinylated, and the 
six well plates coated with avidin and washed  as described above the biotinylated FN 
derivatives were coated on the six well plates using the protocol outlined in section 2.2. 
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2.7. Biotinylation of FN peptides 
 
Biotinylation  of  FN  peptides  was  carried  out  according  to  the  instructions  of  the 
Maleimide-PEO2-Biotin  kit  (Thermo  Scientific).  In  brief,  the  concentration  of  the  FN 
derivatives required was calculated using the calculation described in the protocol (Thermo 
Scientific). The FN derivative was then dissolved to the required concentration in PBS. 
Just  before  use  190µl  PBS  was  added  to  2  mg  Maleimide-PEO2-Biotin  which  would 
produce a 20mM stock solution. The appropriate volume of Maleimide-PEO2-Biotin was 
added to the protein solution as calculated using the calculation outlined in the protocol 
(Thermo Scientific) and the solution mixed. The protein/Maleimide-PEO2-Biotin solution 
was then allowed to incubate for three hours on ice. Biotinylation was then confirmed 
using the HABA method outlined in section 2.8. 
 
 
2.8.a. HABA method 
 
24.2mg of HABA was dissolved in 9.9ml ultrapure water to which was added 100µl 1M 
NaOH. 600µl of the HABA solution and 10mg of avidin (SIGMA) was then added to 
19.4ml PBS. 900µl of HABA/avidin solution was then pipetted into a 1ml cuvette and the 
absorbance measured at 500nm. If mixing the solution has been done correctly the A500 of 
the solution should be between 1.3 to 0.9. To the 900µl HABA/avidin solution 100µl of 
the biotinylated protein was then added, mixed well and the absorbance measured. The 
number of biotin molecules successfully attached to the FN derivatives was then calculated 
using the calculations detailed in the protocol from Thermo Scientific. 
 
 
2.8.b. Labelled protein purification 
 
To remove any excess biotin protein purification was carried out using zeba desalt spin 
columns (Thermo Scientific). The bottom of the 5ml desalt spin column was removed, the 
cap  loosened  and  placed  in  a  collection  tube.  The  spin  column  was  then  spun  in  a 
centrifuge at 1,000 x g for 2 minutes to remove the storage solution contained within the 
column. A mark was placed on the side of the column where the resin is slanted upwards.   44 
The column was then placed with the mark facing outwards for the remainder of the spins. 
2.5ml buffer (PBS) was added to the column and centrifuge at 1,000 x g for 2 minutes. 
This wash step was repeated a further three times. Finally the spin column was placed in a 
new collection tube, the protein sample added then spun again at 1,000 x g for 2 minutes 
and the sample collected. 
 
 
Molecular biology 
 
2.9. RNA extraction 
 
RNase free pipettes obtained from Starlabs were used for all of the molecular biology 
techniques outlined below. RNA was extracted using the RNeasy mini kit following the 
protocol outlined in the RNeasy Mini Handbook (Qiagen) used for monolayer cultures. 
There were several options for lysis of the cells and RNA extraction depending on the 
method of growth. The following method was cited for the initial stages. 600µl RLT buffer 
(10µl β-mercaptoethanol added per 1ml RLT buffer) was added to the cells grown in a 
monolayer. The lysate was then homogenized by aspirating then passing through a 0.9mm 
diameter blunt 20 gauge needle that had an RNase free syringe attached. From here on the 
protocol used is exactly as described in the RNeasy Mini Handbook (Qiagen).  
 
 
2.10. Reverse transcriptase (RT) reaction 
 
The  RT  reaction  was  carried  out  in  accordance  with  the  protocol  specified  for  the 
AffinityScript  Multiple  Temperature  cDNA  Synthesis  Kit  (Stratagene)  with  minor 
alterations. In short, 3µg RNA was made up to 15.7µl with RNase-free water and 1.0µl 
oligo(dT)  (Stratagene) primer was added to the RNA/water solution. The PCR machine 
was then programmed to run the samples for 5 minutes at 65°C, then at 25°C for 10 
minutes.  After  primer  annealing  the  following  was  added  to  each  reaction,  2µl  10x 
AffinityScript RT Buffer (Stratagene), 0.8µl dNTP mix (Stratagene), 0.5µl RNase Block 
Ribonuclease  Inhibitor  (Stratagene),  1µl  AffinityScript  Multiple  Temperature  RT 
(Stratagene). The PCR machine was then set to run at the following temperatures, 42°C for   45 
55 minutes, 95°C for 5 minutes. The cDNA generated was then placed on ice and then 
stored at -20°C. 
 
 
2.11. Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) 
 
In order to test the specificity of the primers designed for use in SYBR green QPCR RT-
PCR  was  carried  out.  To  pre-made  RT-PCR  mastermix  (rovalab)  2µl  cDNA,  1µl 
forward/reverse primer mix (primers obtained from VH Bio) and 2µl RNase-free water 
were added (Ambion). The PCR run was then set as follows, 1. 95°C for 3 minutes, then 2. 
95°C for 15 seconds, 3. 60°C for 20 seconds, 4. 72°C for 40 seconds, 5. Steps 2-4 were 
then repeated for 40 cycles, 5. 72°C for 7 minutes and finally the reaction terminates at 
4°C.  
 
 
2.12. QPCR 
 
SYBR green was used to determine the absolute number of transcripts being produced by 
the  cells.  The  numbers  obtained  were  normalized  to  GAPDH.  (protocol  adapted  from 
McKimmie CS PhD thesis 2005, McKimmie CS and Fazakerley JK 2005) 
 
 
2.13. Designing gene specific primers 
 
Two sets of primers specific for the same gene are required for this method of QPCR, a set 
of standard primers used for the generation of standard cDNA templates and a set of QPCR 
primers that would be used in the QPCR reaction itself.  
The cDNA standards are a larger stretch of cDNA that contain the stretch of cDNA the 
QPCR primers will amplify which is essential for the quantification of the absolute levels 
of  transcripts  present  to  be  accurately  measured.  Primer  3  software 
(http://frodo.wi.mit.edu/) was used for primer design. The ideal criteria for the design of 
primers are described below: 
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-  GC content between 40%-65% (optimal content 50%) 
-  Length of sequence between 18-23 base pairs (bp) 
-  Primer melting temperature (Tm) between 59.5°C - 61°C (optimal temp 60°C) 
-  Maximum self complementarity : 2 
-  Maximum 3’ self complementarity : 1 (This must remain constant) 
-  The size of the amplified QPCR primer product should be 150bp or less 
-  Sequences containing more than 3 C or G bases in a row are to be avoided 
-  A maximum of two C or G bases in the final five bases at the primer’s 3’ end 
 
If the above parameters are followed closely it should result in the generation of primers 
specific for the gene of interest that are unlikely to result in the formation of hair-pin loops 
or primer dimers. It is preferable that primers are generated from sequences within 1500bp 
of the 3’ end of the mRNA. If no specific primers are generated using the above criteria it 
is recommended that the Tm is relaxed to between 58°C - 62°C.  The GC content can also 
be altered to 35% - 70%. Thirdly the maximum self complementarity can be relaxed to 3. 
It should be stressed however that the maximum 3’ self complementarity should not be 
altered and remain at 1. The standard primers are generated in the same fashion as the 
QPCR primers. 
 
 
Once both QPCR primers and standard primers have been designed they must be tested to 
ensure that they are specific for the gene of interest and they do not bind to alternative 
splice  variants  of  the  same  gene  or  indeed  to  another  gene.  Primer  specificity  was 
determined through carrying out RT-PCR using cDNA from a source that is known to 
express  the  gene  being  analysed.  The  products  of  the  PCR  were  separated  using  gel 
electrophoresis through a 2% agarose gel to which was added 1.5µl of ethidium bromide. 
Primers were used providing that upon visualization via gel electrophoresis a single band 
was observed that is approximately the correct size predicted from primer 3 design. A type 
IV hyperladder that measures between 100 – 1,000bps was used to determine if the primer 
product was the correct size.  If two or more bands were visualized on the gel it was an 
indication  that  these  primers  were  not  appropriate  for  use  in  QPCR  due  to  either  non 
specific binding to another gene product/splice variant of the same gene or the formation 
of primer dimer.    47 
 
If either primer dimer occurs or smears of low molecular weight cDNA are visible it is 
possible to optimize the primers to be specific for one particular product through reducing 
the concentration of the primer or increasing the annealing temperature. If no bands are 
observed although it is accepted this cDNA is known to express the gene of interest, then 
reducing the temperature annealing takes place at or increasing the concentration of the 
primers used can often result in the production of PCR product. Although it is possible to 
remove low molecular weight smears through optimizing the conditions at which the PCR 
takes place, if cDNA is detected with a molecular weight greater than the gene of interest it 
is  often  the  result  of  non  specific  binding  to  another  gene  and  new  primers  are  often 
required. 
 
 
2.14. Production of cDNA standards 
 
In order to accurately quantify the levels of a particular gene in a sample a standard curve 
must be generated. Therefore cDNA templates were generated by carrying out RT-PCR 
with the standard primers and purifying the cDNA obtained on a PCR purification column 
according  to  instructions  laid  out  in  the  protocol  (Qiagen  QIAquick  columns).  The 
standard generated was then serially diluted by a factor of 10. The QPCR primers were 
then used to amplify the particular sequence of interest and the serial dilutions are used as 
the template for the QPCR. Through use of cDNA standards it is possible to quantify the 
absolute transcript levels of the gene of interest.  
 
 
To  quantify  the  mass  of  each  standard  PCR  product  the  optical  density  (O.D.)  was 
examined using a spectrophotometer then the following calculation carried out;  
O.D. x dilution factor x 50 
Once the mass of the standard was determined the following calculations are carried out to 
determine  the  copies  of  each  transcript.  An  example  calculation  is  given  below  using 
mouse Oct-4 as an example: 
 
Oct-4 PCR product has a mass of 6.78 x 10
-8g/µl
 and a base pair size of 901. At first, the 
molecular weight of this PCR product was determined.   48 
 
Average molecular weight for double stranded nucleotide = 660 daltons 
Molecular weight of double stranded DNA = 660 daltons x length of standard in bp 
Molecular weight of double stranded DNA = 660 x 901 
Molecular weight of double stranded DNA = 594,660 daltons 
 
Number of moles of standard = mass in grams per µl / Molecular weight of DNA 
Number of moles of standard = 6.78 x 10
-8 / 594,660 = 1.1403 x 10
-13 moles per µl 
 
In order to determine the copy number from the number of moles Avagadro’s constant is 
used.. 
Copies DNA per µl = Avagadro’s constant x moles per µl 
Copies DNA per µl = (6.02 x 10
23) x (1.1403 x 10
-13 moles) 
Copies DNA per µl = 6.863 x 10
10 copies per µl 
 
Standards of varying concentrations were used to obtain a good standard curve ranging 
from 1 x 10
-5 to 1 x 10
-9 dilutions of the original standard. Purified concentrated standard 
was first diluted to a concentration of 1 x 10
-2 using 10mM TE buffer and stored for all 
future dilutions. Any further dilutions of the 1 x 10
-2 standard used nuclease free water 
(Ambion) to dilute the standard. An example of a standard curve graph is shown in figure 
2.1. 
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Figure  2.1. Example of a standard curve used for absolute quantification of transcripts 
 
Figure 2.1 is an example of an accurate standard curve that can be used for the absolute 
quantification of transcripts as it fulfills the following requirements, 
-The r
2 value is >0.98. If the r
2 is less than 0.98 then the data was excluded from the 
results. 
-The slope should be 3.3. This means that the PCR product has been amplified every 3.3 
cycles by a factor of 10. This infers that reaction efficiency is 100%  
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Figure 2.2 Dissociation curve 
 
Figure 2.2 is an example of a dissociation curve. This is used to determine whether or not 
the primers were specific for the gene of interest. If this was the case there would be one 
peak as the gene of interest is amplified which is the case in figure 2.2. It also allows the 
user  to  visualize  that  every  sample  has  been  amplified.  The  non-amplified  flat  lines   51 
observed near the bottom of the amplification plot are the non template control which of 
course will not be amplified. 
 
2.15. SYBR green QPCR protocol 
 
All samples were used in triplicate during the QPCR assay. A complete QPCR solution 
(called master-mix from here on) was made up immediately prior to preparing the samples 
for QPCR. 20% more master-mix than required was produced to ensure that there would 
be  enough  if  any  errors  in  aliquoting  the  master-mix  occurred.  For  each  individual 
triplicate reaction the following was required; 
 
- 0.8µl QPCR primer mix (initial stock of 60µl of both forward and reverse QPCR primers 
mixed together, obtained from VH Bio) 
- 8µl nuclease free water (Ambion) 
- 10µl Power SYBR green mix (Applied Biosystems) 
      
To each well 6µl of either a cDNA sample or cDNA standard was added plus 54.5µl of 
QPCR master-mix. This QPCR master-mix/sample or QPCR master-mix/standard solution 
was pipetted up and down five times to ensure proper mixing. Pipetting up and down had 
to be uniform for all the samples. Failing to do this often resulted in wide variations in 
terms  of  results.  After  mixing  the  master-mix/sample  solution  19.8µl  of  the  master-
mix/sample solution was aliquoted into a well in a 96-well reaction (MicroAmp) plate 
(Applied Biosystems), then 19.8µl aliquoted into the adjacent two wells. 19.8µl was used 
to ensure that there is enough to successfully aliquot triplicates of the same volume and 
concentration to each well. To examine the detection potential of the QPCR assay and to 
determine the possibility of contamination a non-template control (NTC) was incorporated 
into the experiment. For NTC samples 6µl of nuclease free water was added to 54.5µl of 
master-mix  then  19.8µl  aliquoted  into  triplicates.  The  limit  of  detection  of  this  QPCR 
assay is the result of one of two reasons; the amplification of non-specific primer-dimer 
which can occur in a sample with little to no cDNA template such as the NTC or the 
backgound contamination level. Once the samples have been aliquoted into the Microamp 
plates it was spun at 400 x g for 15 seconds to ensure that the sample was all on the bottom   52 
of the well. Bubbles in the wells are not a cause for concern as they will be removed 
through heating that will occur in the QPCR assay. 
 
 
2.16. Normalizing cDNA samples to GAPDH 
 
In  order  to  compare  gene  transcript  levels  between  samples  the  levels  of  cDNA  were 
normalized.  To  normalize  the  samples  housekeeping  genes  were  used.  Housekeeping 
genes are genes that are expressed in all cells, have a role in the metabolism of the cell and 
have no apparent role in cell differentiation. The housekeeping gene used to normalize the 
samples  in  the  QPCR  assays  described  in  this  text  was  Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH). This gene codes for a glycolytic enzyme that is involved in 
catalyzing  the  oxidative  phosphorylation  of  glyceraldehyde-3-phosphate  into  1,3-
diphosphoglycerate. 
 
To calculate the absolute transcripts normalized to GAPDH the following calculation was 
carried out; 
Copy number of gene of interest/Copy number of GAPDH housekeeping gene x 10
5. 
This will give the copy number of the gene of interest per 100,000 GAPDH. The copy 
number of GAPDH was determined using the O.D. method as described previously. It is 
important that the correct housekeeping gene is chosen as there is a tendency for cultured 
cell line’s transcript levels to be affected by one’s test in comparison to one’s control. This 
was tested prior to the commencement of QPCR and it was confirmed that the transcript 
levels  of  GAPDH  were  unaffected  by  growing  ES  cells  on  either  surface  coating. 
Therefore GAPDH was considered as a suitable housekeeping gene. While it would be 
prudent to use several housekeeping genes if different tissues were tested as 1 ES cell line 
ie E14’s were used only 1 housekeeping gene was required. 
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Chapter 3 Results 
 
3.1. Comparison of the adhesive ability of 2-D polyvalent displays with non-biotinylated 
FIII9-FIII10 derivatives 
 
The first question to be answered in this project was whether or not the specific orientation 
of cell support displays in any way significantly enhanced the adhesive properties of the 
FIII9-FIII10  derivatives.  It  has  been  argued  that  control  over  aspects  such  as  the 
orientation and density of the ligand must be addressed if adhesive support systems are to 
be as functionally useful as possible (Kreiner et al 2008). Therefore an experiment was 
designed to test if fixing the FIII9-FIII10 derivatives in a specific conformation through 
generation of 2-D polyvalent displays enhanced the number of colonies that would form 
compared when the FIII9-FIII10 derivatives were distributed in a random fashion. 
 
 
 In order to test the potential of these 2-D polyvalent displays for enhancing the growth of 
ES  cells,  FIII9-FIII10  derivatives  were  biotinylated  at  the  C-terminal  cysteine  residue 
using  the  biotin-PEO-malemide  kit  and  immobilized  on  six  well  plates  coated  with 
streptavidin.  In  addition  six  well  plates  were  also  coated  with  FIII9-FIII10  derivatives 
without  prior  biotinylation  to  examine  the  importance  of  orientation  for  any  effects 
observed. ES cells were also grown on gelatin coated six well plates, a common substrate 
for ES cell growth and finally on avidin coated plates to look at the potential positive or 
negative effect this substrate has on ES cell growth. The dimeric form of the FIII9-FIII10 
derivatives was chosen for this experiment over the other conformations as FN most often 
is  found  composed  of  two  monomers  which  both  contain  the  FIII9-FIII10  domains 
essential for cell adhesion and spreading (Mardon and Grant 1994). In addition one would 
expect that the dimeric version of the FIII9-FIII10 derivatives would very closely mimic 
the  effect  the  other  derivatives  have  due  to  the  close  similarity  of  their  amino  acid 
sequences. As shown in figure 3.1, there appeared to be no significant improvement upon 
using 2-D orientated polyvalent displays on the attachment potential of the dimeric FIII9-
FIII10 derivatives in comparison to dimeric FIII9-FIII10 derivatives that had not been 
attached in a specific conformation. This calls into question the notion that the specific 
orientation of cell growth surfaces in any way enhances their adhesive potential (Kreiner et   54 
al 2008, Koo et al 2002, Irvine et al 2002, Maheshwari et al 2000). There was almost a 
complete absence of ES cell colonies of any kind on plates coated with avidin. Evidently 
this surface is not supportive of ES cell growth.  
 
               
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Comparison of biotinylated and non biotinylated FIII9-FIII10 dimer’s adhesive potential. 
300µg/well of either biotinylated or non biotinylated FIII9-FIII10 dimer, 0.1% gelatin or 25µg/well 
Avidin were coated on a six well plate. ES cells were grown for 3 days in complete medium, stained 
with giemsa and 10 counts/well taken at 5x magnification. 1,000 ES cells seeded/well. Comparison of 
gelatin and the biotinylated or non biotinylated FIII9-FIII10 dimer coated plates to adhere ES cell 
colonies were tested using an unpaired student’s t test used.  P<0.0001 = *** , n = 10 
 
 
There were two observations that were worth closer examination however. First, plates 
coated with either the 2-D orientated polyvalent displays or the non biotinylated FIII9-
FIII10  derivatives  supported  a  significantly  greater  number  of  ES  cell  colonies  when 
compared to gelatin. This is potentially useful as these FIII9-FIII10 derivatives could be 
used  as  an  alternative  surface  for  ES  cell  growth.  It  was  also  noted  that  in  terms  of 
morphology the ES cells colonies grown on the FIII9-FIII10 derivatives were markedly 
different when compared with ES cells grown on gelatin coated dishes. ES cells grown on 
gelatin had the classical round appearance of undifferentiated ES cells. In contrast ES cells 
grown on the FIII9-FIII10  derivatives, regardless of biotinylation had a more flattened 
0
5
10
15
20
25
30
35
40
45
*** ***  55 
morphology, which is a characteristic of differentiated ES cells as shown in figure 3.2. 
These morphological changes were all the more interesting when one considers these ES 
cells were cultured in the presence of LIF. 
 
 
                    
 
 
 
 
 
A                  B  
Figure 3.2 ES cells grown in complete media for 3 days then stained with 10% giemsa on A. Gelatin 
coated six well plates or B. FIII9-FIII10 derivative coated six well plates. Magnification x20. Complete 
media  was  used  to  culture  the  ES  cells  grown  on  gelatin  or  FIII9-FIII10  derivatives.  Media  was 
changed daily. 
 
 
The steps taken to determine whether or not ES cells grown on the FIII9-FIII10 derivatives 
were differentiating even in the presence of LIF through use of QPCR are dealt with later 
in the text. However, initially, data relating to the adhesive properties of the FIII9-FIII10 
derivatives are presented. 
 
 
3.2. Optimal conformation of FIII9-FIII10 derivatives for ES cell adhesion 
 
With a lack of any discernable advantage in terms of attaching colonies of ES cells using 
2-D orientated displays as opposed to using non-biotinylated FIII9-FIII10 derivatives the 
generation of orientated 2-D polyvalent displays was abandoned and attention was focused 
on the effects of the FIII9-FIII10 derivatives on ES cell function and morphology. The 
FIII9-FIII10 derivative was available in four states, ie monomeric, dimeric, trimeric and 
tetrameric.  Therefore  steps  were  taken  to  determine  which  of  the  derivatives  had  the 
greatest adhesive potential. To this end a protein titration was carried out using the four   56 
derivatives at various concentrations with ES cells grown on them for 3 days. After 3 days 
growth the ES cells were stained using giemsa and the colonies counted using the colony 
counting method detailed in section 2.3 of materials and methods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Comparison of ES cell colony supporting potential of all four FIII9-FIII10 derivatives and 
0.1% gelatine control at the following concentrations; 2µg/ml, 10µg/ml, 20µg/ml, 100µg/ml, 200µg/ml, 
300µg/ml n =30. 1,000 ES cells seeded/well. Complete media was used to culture the ES cells grown on 
gelatin or FIII9-FIII10 derivatives. Media was changed daily. 
 
 
As can be observed from figure 3.3 the optimal FIII9-FIII10 derivative in terms of its 
ability to support ES cell colony growth appears to be the dimeric form. Although not 
statistically significantly more efficient at supporting ES cell colony growth compared to 
the other derivatives the dimer appears consistently better than the other derivatives, even 
if only subtly so. It appears that the optimal concentration for supporting ES cell colony 
growth has not been established in this assay. A dose response curve is clearly visible in 
figure 3.3 with no apparent saturation point as the number of ES cell colonies does not 
plateau at the concentrations of FIII9-FIII10 derivatives used. In order to confirm that the 
dimeric form of the FIII9-FIII10 derivative was indeed the most efficient at supporting ES 
cell  colony  growth  a  second  experiment  was  set  up  in  order to  determine  the  cloning 
efficiency of ES cells on all four FIII9-FIII10 derivatives. The cloning efficiency is simply 
a percentage of the number of ES cells seeded that form colonies. Six-well plates were 
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therefore coated with one of the four FIII9-FIII10 derivatives, or gelatin, then ES cells 
were seeded and allowed to grow for six days. After six days the media was removed and 
the ES cells stained using giemsa as detailed in materials and methods section 2.3. and 
cloning efficiency determined as described in materials and methods section 2.4b. 
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Figure 3.4 Cloning efficiency of all four FIII9-FIII10 derivatives compared to gelatin coated dishes. 
50µg/well of the derivatives were used and 0.1% gelatin used as a control. 1,000 ES cells seeded/well. 
Complete media was used to culture the ES cells grown on gelatin or FIII9-FIII10 derivatives. Media 
was changed daily. An unpaired student’s t test was carried out comparing the adhesive abilities of the 
gelatin control with each of the FIII9-FIII10 derivatives. P<0.006  = **, P<0.05 = *  n = 6 
 
 
The results of the cloning efficiency experiment presented in figure 3.4 confirm the data 
shown in figure 3.3 in that the FN derivative most effectively support ES cell growth when 
in dimeric form. It confirms that although the dimer is not significantly better at supporting 
ES  cell  colonies  compared  to  the  monomeric,  trimeric  or  tetrameric  forms  of  the 
derivatives it is consistently more efficient. In addition it should also be noted that at 
50µg/ml concentration, all of the FIII9-FIII10 derivatives supported a statistically greater 
number of ES cell colonies than gelatin controls. 
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3.3. Effect of FN derivative on ES cell proliferation 
 
There was a visible alteration of the morphology of the ES cells grown on the FIII9-FIII10 
derivatives. An experiment was also set up to investigate whether or not the derivative had 
any effect on the proliferation of ES cells. To do this six well plates were coated with one 
of the four FIII9-FIII10 derivatives, or gelatin, and compared at different time points to 
examine any potential effect these proteins may or may not have on ES cell proliferation.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Proliferation of ES cells cultured on the various FIII9-FIII10 derivatives. 100µg/well of any 
one of the FIII9-FIII10 derivatives were added to each well. 20,000 ES cells seeded/well. Complete 
media  was  used  to  culture  the  ES  cells  grown  on  gelatin  or  FIII9-FIII10  derivatives.  Media  was 
changed  daily. No significant  difference in the number of cells were observed when  ES  cells were 
plated on either gelatin or the FIII9-FIII10 derivatives. 
 
It  is  very  clear  from  figure  3.5  that  the  FIII9-FIII10  derivatives  play  no  role  in  the 
proliferation of ES cells as there is no difference in the number of cells, either between the 
different forms of the FIII9-FIII10 derivatives or the gelatin controls. Figure 3.5 follows 
the stereotypical lag, log and plateau phases of cells placed in a new environment. Initially 
there is a lag phase while the ES cells become attached and form colonies after they have 
been newly plated. Then at day 3 there is a substantial increase in cell numbers regardless 
of the media plated. Then as the ES cell confluency increases the level of proliferation 
drops  in  an  attempt  to  maintain  equilibrium  with  the  environment  the  ES  cells  find 
themselves in. This data has been confirmed by a publication from another group looking 
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at the effect of various ECM components on ES cells (Hayashi et al 2007). Although this 
study used whole FN the effect was the same in that there was no enhanced proliferation of 
ES cells when grown on whole FN or indeed any of the ECM components tested (Hayashi 
et al 2007). 
 
 
3.4. Comparison of the adhesive abilities of dimeric FIII9-FIII10 derivative with whole FN 
 
As the dimeric form of FIII9-FIII10 had a modest but noticeably greater ability to allow 
the growth of ES cell colonies the next question to ask was whether or not these FIII9-
FIII10 derivatives have greater potential in this regard than whole FN. This is of interest as 
FN in its intact form is commercially expensive to make and purify. If the FIII9-FIII10 
derivative could support the growth of a greater number of colonies or cells than whole FN 
then it could have some commercial advantages in that it would be cheaper to generate and 
purify  these  FIII9-FIII10  derivatives  as  opposed  to  whole  FN.  In  addition  one  of  the 
commercial problems with whole FN is the difficulty to ensure its purity. (Chris Walle, 
personal communication).  
 
 
If these FIII9-FIII10 peptides were shown to be adequate for supporting cell adhesion then 
it would be a way of controlling the exact structure of the FN being used. Therefore the 
ability of dimeric FIII9-FIII10 and whole FN on a microgram for microgram and mole for 
mole basis was compared in order to determine the ES cell supportive potential of the 
FIII9-FIII10 peptides as compared with conventional whole FN. When the FIII9-FIII10 
derivative and whole FN were compared using an equal number of micrograms it is clear 
the FIII9-FIII10 derivative has a significantly greater ability to support colony growth as 
shown in figure 3.6. This effect was noted for both the number of colonies counted and 
also in terms of cloning efficiency. A second point to be made was that both the FIII9-
FIII10 dimer and whole FN enabled a significantly greater number of cells to attach when 
compared with gelatin controls. 
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Figure 3.6 Comparison of the colony supporting ability of the dimeric FIII9-FIII10 and whole FN at 
equal microgram concentrations. In figure 3.6A ES cells were grown on either 50µg/well of dimeric 
FIII9-FIII10 or whole FN or 0.1% gelatin for 3 days, stained with giemsa and counted. In figure 3.6B 
ES cells were grown for 6 days on the dimeric FIII9-FIII10, whole FN or gelatin, stained with giemsa 
then the cloning efficiency determined. Dishes were coated with 0.1% gelatin or 50µg/well of dimeric 
FIII9-FIII10 or whole FN diluted in protein buffer. 1000 ES cells/well seeded. In both experiments 
complete media was used to culture the ES cells grown on gelatin or dimeric FIII9-FIII10. Media was 
changed daily. 
 
 
If the FIII9-FIII10 dimer is compared to whole FN on a mole for mole basis the opposite 
effect is seen to that observed in figure 3.6. It is clear from figure 3.7 that whole FN has 
markedly greater colony supportive abilities than that of the FIII9-FIII10 dimer when used 
at the same molar concentration. This trend is seen once more when the cloning efficiency 
is tested. There is no difference in the number of colonies supported by gelatin or the 
FIII9-FIII10 dimer due to the low concentration of the FIII9-FIII10 dimer required in order 
to set up a mole for mole comparison with intact FN. Intact FN has a molecular weight of 
440-500kDa  compared  to  the  FIII9-FIII10  derivatives  molecular  weight  of  29.7kDa. 
Therefore 2.97µg/ml of FIII9-FIII10 derivatives has the same number of molecules as 
50µg/ml intact FN and these were the concentrations of the two proteins used for this 
experiment. 
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Figure 3.7 Comparison of the colony supporting ability of the dimeric FIII9-FIII10 and whole FN at 
equal mole for mole concentrations. In figure 3.7A ES cells were grown on either the dimeric FIII9-
FIII10 derivative or whole FN for 3 days, stained with giemsa and counted. In figure 3.7B ES cells 
were grown for 6 days on either the dimeric FIII9-FIII10 derivative, whole FN or gelatin, stained with 
giemsa and the cloning efficiency determined. Dishes were coated with 0.1% gelatin or an equal mole 
for mole concentration of dimeric FIII9-FIII10 (2.97µg/ml) or whole FN (50µg/ml) diluted in protein 
buffer. 1,000 ES cells/well seeded. In both experiments complete media was used to culture the ES cells 
grown on gelatin or the FIII9-FIII10 dimer. Media was changed daily. 
  
 
3.5. Effect of LIF titration of ES cell morphology 
 
As ES cells grown in six well plates coated with the FIII9-FIII10 dimer appeared to show 
some morphological changes characteristic of differentiating ES cells, even though these 
ES cells were grown in the presence of LIF, the question was asked whether this apparent 
phenotypical differentiation could be altered through increasing the concentration of LIF. 
Therefore  ES  cells  were  grown  on  dimeric  FIII9-FIII10  in  the  presence  of  media 
containing either, the standard LIF concentration (1,000units LIF/ml) required for long 
term ES cell culture, or 5,000 or 10,000 units of LIF/ml. These cells were cultured then 
giemsa stained after 3 days growth. At first colony formation analysis was performed in 
order to determine whether or not increasing the concentration of LIF in the media had any 
effect on the number of colonies formed. As figure 3.8 clearly displays there is no effect on 
the number of colonies formed upon increasing the concentration of LIF in the media. This 
was not at all unexpected as LIF’s most characterised role is the maintenance of ES cells in 
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an undifferentiated state (Smith et al 2001) whereas there is little evidence that LIF plays 
any role in supporting ES cell colony formation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 Effect of LIF titration on colony numbers. 1,000 ES cells/well were seeded and grown in 
media containing 1,000, 5,000 or 10,000 units of LIF/ml on either 50µg/well FIII9-FIII10 dimer or 
0.1%  Gelatin.  The  media  used  was  changed  daily.  The  colony  counting  technique  described  in 
materials and methods was used to count the colonies, n = 30 
 
 
Although increasing the concentration of LIF in the media had no effect on ES cell colony 
numbers  upon  closer  inspection  of  the  colonies  it  was  apparent  that  there  were  some 
peculiar  morphological  differences.  There  appeared  to  be  different  types  of  colonies 
forming in terms of their phenotype. Some colonies were made up of a tight cluster of cells 
which  is  characteristic  of  undifferentiated  ES  cell  colonies  and  were  round  in  shape 
whereas other colonies had a more dispersed morphology. Examples of these colonies are 
given in figure 3.9. The ratios of these “tight” and “dispersed” colonies seemed to change 
depending on the concentration of LIF used. Therefore the number of tight and dispersed 
colonies were counted using the colony counting technique described previously (materials 
and methods section 2.4.). 
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Figure 3.9.A. Tight colonies, 3.9.B. Dispersed colonies. Magnification x20. ES cells grown on 50µg/well 
FIII9-FIII10 dimers for 3 days then stained with 10% giemsa. Media was changed daily. 
 
Upon counting the numbers of tight and dispersed colonies at the various concentrations of 
LIF used it was noted that the ratios of both types of colonies did indeed alter when LIF 
concentration was increased.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10 Changes in the number of tight and dispersed colonies upon titration of LIF. Six well 
plates were coated with FIII9-FIII10 dimer at 50µg/well. 1,000  ES  cells were  seeded  per well and 
grown in complete media containing 1,000,5,000 or 10,000 units of LIF/ml. n = 30. Media was changed 
daily. 
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Figure  3.10  shows  that  at  1,000  Units  of  LIF/ml  the  colony  phenotype  that  tends  to 
dominate is the dispersed phenotype. This is consistent with the partially differentiated 
phenotype observed when ES cells were first grown on FIII9-FIII10 dimer as discussed 
earlier. Increasing the concentration of LIF to 5,000 Units of LIF/ml reduced the number 
of dispersed colonies concomitant with  an increase in the number of tight colonies. It 
appears that at 5,000 units of LIF/ml the undifferentiated phenotype of ES cell colonies is 
now more dominant than the differentiated morphology. Increasing the concentration of 
LIF used in the media to 10,000 Units of LIF/ml has a clear effect on the numbers of tight 
and dispersed colonies with significantly more tight colonies being observed compared 
with dispersed colonies. This could be a sign that any potential differentiating signals that 
the FIII9-FIII10 dimer triggers in ES cells may be inhibited by increased concentrations of 
LIF drowning the signal out. This is very possible as even at standard LIF concentrations 
of  1,000  Units  of  LIF/ml  there  are  ES  cells  that  maintain  a  more  undifferentiated 
morphology and look similar to tight colonies suggesting that LIF signalling via the LIF 
receptor is dominant over the FN-integrin receptor interaction. A final point of note to be 
taken from this experiment is the overall number of colonies observed remains consistent 
regardless of the concentration of LIF used, though the phenotypes of these clonies do alter 
with altered LIF concentration. 
 
 
3.6. Alkaline phophatase staining 
 
As  there  appeared  to  be  some  phenotypic  indication  that  ES  cell  differentiation  was 
occurring due to the flattened morphology of some of the ES cells plated onto the FIII9-
FIII10 dimer, alkaline phosphatase staining was carried out to determine whether or not ES 
cell differentiation was taking place. Alkaline phosphatase is a marker expressed on ES 
cells when they are cultured in an undifferentiated state. Upon differentation of ES cells 
alkaline phosphatase ceases to be produced. Undifferentiated ES cells will stain pink for 
alkaline phosphatase staining whereas differentiated ES cells will be clear upon staining 
for the presence of alkaline phosphatase. ES cells were therefore grown as a monolayer on   65 
gelatin or the FIII9-FIII10  dimer and cultured in complete medium in the presence or 
absence of LIF. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11 Alkaline phosphatase staining. ES cells were grown on either 50µg/well FIII9-FIII10 dimer 
or 0.1% gelatin for 5 days. Alkaline phosphatase staining was carried out after 5 days of culturing. 
Alkaline phosphatase positive and negative colonies were counted using the colony counting method 
described in materials and methods. N = 30. 1,000 ES cells seeded/well. 
 
 
The results obtained, shown in figure 3.11, were contrary to expectations. Although there 
appeared to be a flattening of the ES cells, which is a morphological indication that ES cell 
differentiation  may  be  occurring,  no  difference  was  observed  in  alkaline  phosphatase 
positive staining between the gelatin or dimeric FIII9-FIII10 grown ES cells. ES cells 
grown  in  the  presence  of  LIF  were  approximately  90%  alkaline  phosphatase  positive 
which is the percentage expected of an undifferentiated ES cell population. Upon removal 
of LIF the alkaline phosphatase positive ES cell number markedly reduced confirming the 
role of LIF in the maintenance of ES cells in an undifferentiated state (Smith 2001).  
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Figure  3.12  Alkaline  phosphatase  stained  ES  cells  grown  on  A.  Gelatin  B.  FIII9-FIII10  dimer  in 
complete media containing 1,000 Units/ml LIF or C. Gelatin D. Fn dimer in complete media minus LIF 
Media changed daily. 1,000 ES cells seeded/well. x20 magnification.  
 
As shown in figure 3.12, ES cells grown in the presence of LIF on gelatin or the FIII9-
FIII10 dimer are both highly alkaline phosphatase positive However upon detailed analysis 
of the images it becomes apparent that while ES cells grown on gelatin are uniformly 
round, ES cells grown on the FIII9-FIII10 dimer have a more flattened morphology at the 
colony edges. It is possible that the there is a layer of more flattened ES cells at the bottom 
of the ES cell colony which are receiving a differentiation stimulus from the FIII9-FIII10 
dimer.  However  upon  formation  of  the  colony,  ES  cells  grow  on  top  of  the  layer  of 
   
A  B 
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flattened ES cells thus do not receive the differentiation stimulus. Removal of LIF results 
in a substantial reduction in the percentage of alkaline phosphatase positive colonies and 
those, which do remain positive, are not uniformly positive as seen in figure 3.12. There 
appeared to be no major differences in morphology when LIF is removed and the ES cells 
allowed to differentiate on either gelatin or the FIII9-FIII10 dimer.  
 
 
3.7. Transcriptional analysis of ES cells grown on the FIII9-FIII10 dimer 
 
The alkaline phosphatase data presented in figure 3.11 suggested that the morphological 
changes observed through use of giemsa stain may have been just that, i.e. morphological 
with  no  apparent  differentiation  occurring  in  terms  of  loss  of  alkaline  phosphatase 
expression. However the possibility could not be ruled out altogether that the FIII9-FIII10 
dimer  could  aid  in  the  differentiation  of  ES  cells  and  it  remained  possible  that  the 
interaction  of  LIF  binding  via  the  LIF  receptor  was  simply  dominant  the  FIII9-FIII10 
dimer’s pro-differentiation signals. To investigate this possibility a transcriptional analysis 
of a variety of genes expressed by ES cells was undertaken. Therefore, ES cells were 
grown on gelatin or the FIII9-FIII10 dimer in the presence or absence of LIF, their RNA 
extracted, converted to cDNA then QPCR carried out.  
 
 
The time points studied were 3 days and 6 days after culturing on the different surface 
coatings and media. Day 3 was chosen as a suitable time for analysis as this was the time 
point at which morphological differences between ES cells grown on gelatin or the FIII9-
FIII10 dimer were initially identified. Secondly, in this assay day 3 appears to be important 
as figure 3.5 shows that proliferation of ES cells starts at this time point. Day 6 was chosen 
as the second time point of investigation as when using this particular assay the ES cells 
are roughly 70-80% confluent after 6 days of culture. To leave it any longer would risk 
over-confluency. The SYBR green standard curve method was used for QPCR as this 
assay  has  the  advantage  of  determining  the  absolute  numbers  of  transcripts  whereas 
Taqman will only generate the fold change of any transcript levels. Although the absolute 
number of transcripts is often not essential the ability to look at these levels then if you 
wish  convert  to  fold  change  was  the  factor  that  helped  us  decide  to  use  this  method. 
Primers designated QPCR primers and Standard primers were both generated for the same   68 
genes of interest as both are required for the absolute quantification of ES cell transcripts 
as detailed in section 2.13 of materials and methods. 
 
In order to carry out SYBR green QPCR we had to generate our own primers specific for 
the genes of interest as outlined in materials and methods (materials and methods sections 
2.12., 2.13.). We took a wide selection of genes that were indicative of differentiation into 
the three germ layers. However, the majority of genes assayed for were mesodermal in 
origin as there is literature suggesting that the interaction of FN with ES cells has a role in 
mesodermal  development,  see  section  1.7.  The  genes  assayed  for,  and  their  primer 
sequences, are detailed in box 1. 
 
Box 1. Primer sequences. 
 
Primer optimisation 
 
Once potential primer sequences had been identified they were purchased and then tested 
to determine whether or not they would be suitable for QPCR, i.e. are they specific for the 
QPCR primers
Gene
Lineage 
marker QPCR1 (Forward primers 5'-3') QPCR2(Reverse primers 5'-3')  Product size
Pou5f1/Oct4                                                           136
Nanog Pluripotency ctctcctcgcccttcctct accttgttctcctcctcctca 123
Ehox                                                          138
Flk1/kdr                                                      100
Nkx2.5                                                        123
Tal 1/Scl                                                      109
Gata-1                                                           153
Brachyury Mesodermal ccaaagaaagaaacgaccaca gaacaagccacccccatt 87
CD34 Mesodermal cctacttcctttgtgctctcctc tccaccattctccgtgtaataag 113
Foxa2 Endodermal tgagtggagactttgggagag agggacacagacaggtgagac 86
Nestin Ectodermal acctttgggtctctggaaaaa agggttcactgtcatctgctc 138
Standard 
Primers
Gene
Lineage 
marker
Standard 1 (Forward primers 5'-
3')
Standard 2 (Reverse primers 5'-
3')
Pou5f1/Oct4                                                             901
Nanog Pluripotency ggtgtcttgctctttctgtgg gcacttcatcctttggttttg 624
Ehox                                                               504
Flk1/kdr                                                     2000
Nkx2.5                                                        446
Tal 1/Scl                                                     1757
Gata-1                                                            544
Brachyury Mesodermal cggtgctgaaggtaaatgtgt gtgtgtggaggggagagaga 605
CD34 Mesodermal gatggctgttgggaagaaaa agaggcgagagaggagaaatg 628
Foxa2 Endodermal acatcaccacagccaccac gccataaataaagcacgcaga 782
Nestin Ectodermal ccctcaaccctcaccactc Tgtctccatacctccttcattca 1922  69 
gene of interest. This was carried out using RT–PCR with cDNA known to express these 
genes at the transcript level. The cDNA used was a mix of  all of the cDNA samples 
obtained from ES cells grown on gelatin or the FIII9-FIII10 dimer on days 3 and 6. All of 
the genes described in box 1 are well known to be expressed within ES cells, so it was felt 
that this would be appropriate.  
1       2         3         4        5        6        7         8         9         10                                             
A             
1     2      3        4        5                                          1    2      3             1                        2             
B            C             D 
 
 
 
 
Gel A
1 Type IV hyperladder
2 Foxa2 QPCR
3 Foxa2 Std
4 Brachyury QPCR primer dimer
5 Brachyury Std
6 Nanog QPCR
7 Nanog Std
8 CD34 QPCR
9 CD34 Std
10 Type IV hyperladder
Gel B
1 Type IV hyperladder
2 GATA-1 QPCR
3 GATA-1 Std
4 SCL QPCR
5 GATA-1 Std
Gel C
1 Type IV hyperladder
2 Nestin QPCR
3 Nestin Std
Gel D
1 Brachyury QPCR
2 Type IV hyperladder
Figure 3.13 PCR products of QPCR and 
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Figure 3.13 continued 
 
A type IV hyperladder which allows assessment of the size of bands between 1,000bps to 
100bps was added to each gel to confirm that the PCR product being formed was the 
correct length. This, in conjunction with only one band forming per lane, would reinforce 
the specificity and accuracy of the PCR primers being used. In gel A there are three wells 
in which multiple bands are found. These bands were intentionally left in so that certain 
aspects of PCR could be discussed. Lanes 3 and 5 of gel A have one strong band and 
several much lighter bands. The darkest, most intense band is the desired product whereas 
the lighter bands are evidence of the primers binding non-specifically to other genes and/or 
the formation of primer dimer structures. The PCR products in these wells were used to 
generate  the  standards  to  quantify  the  numbers  of  transcripts  being  produced  when 
normalised to GAPDH. Providing the QPCR primers used for the same gene were specific 
(ie one band on the gel) this would allow these primer pairs to be used as the QPCR 
primers. These QPCR primers would then bind to a much smaller region of the same gene 
that  is  found  within  the  product  generated  by  the  standard  primers.  Lane  4  of  gel  A 
 
 
Gel E
1 Type IV hyperladder
2 Flk-1 Std
3 Flk-1 QPCR
4 NKX2.5 Std
5 NKX2.5 QPCR
Gel F
1 Type IV hyperladder
2 Oct-4 QPCR
3 Oct-4 Std
4 Ehox QPCR
5 Ehox Std  71 
(Brachyury)  contains  one  very  strong  band  but also  another  much  lighter  band  that  is 
evidence of non-specific binding or primer dimer. As the primer set being used for this 
PCR was a QPCR primer set these primers were deemed unsuitable for QPCR. Therefore 
another  set  of  QPCR  primers  were  used  that  would  amplify  a  region  of  the  product 
generated by the Brachyury standard primer set. The product formed from this new set of 
primers is shown in gel D, lane 1. The sequence and size of the PCR products are listed 
within box 1. The non-specific brachyury QPCR primers were omitted from table 1 to 
avoid confusion.  
  
 
The first gene to be analysed was Oct-4. As discussed in the introduction Oct-4 is essential 
for the maintenance of pluripotency of ES cells (Smith A 2002). In addition to being 
essential for maintaining ES cells in an undifferentiated state it can also play a role in the 
differentiation of ES cells (Niwa et al 2000). Therefore analysis of this gene was an ideal 
place to start. 
 
 
 
 
 
 
 
 
 
 
 
A              B 
Figure 3.14  QPCR analyses of Oct-4 transcript  levels  grown on either 0.1% gelatin or 100µg/well 
dimeric FIII9-FIII10 in media that either, A. contained LIF or B. lacked LIF. N = 6. 20,000 ES cells 
seeded/well. 
 
Interestingly when ES cells were grown on dimeric FIII9-FIII10 there was an increase in 
the number of transcripts being produced at day 3. This was of potential interest as if the 
transcript numbers were converted to fold change there was just under a two fold increase 
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in the number of transcripts in ES cells grown on the FIII9-FIII10 dimer compared to ES 
cells grown on gelatin. There is evidence that an increase in Oct-4 levels is involved in the 
differentiation of ES cells into the mesodermal/endodermal lineage (Niwa et al 2000). ES 
cells grown on the FIII9-FIII10 dimer in the absence of LIF also had an increase in the 
number of transcripts on day 3 compared to gelatin controls. However this increase, while 
being consistent, was not significant although the trend is similar to ES cells grown in the 
presence of LIF.  
 
 
A final point of note was the general reduction of in the level of transcripts detected upon 
removal of LIF. This is a general feature of the the assays carried out using FCS complete 
medium. It is possible this could be due to the transcriptional leakage (Hurst et al 2004, 
Yanai et al 2006). ES cells are well known for their ability to form almost any type of cell 
or tissue, therefore they are very transcriptionally active when maintained in the presence 
of LIF (Graham GJ, personal communication). When LIF is removed and ES cells allowed 
to differentiate many genes are switched off at the transcriptional level only to become 
activated  again  at  a  later  time.  It  is  possible  this  phenomenon  is  responsible  for  the 
differences in transcript levels observed. 
 
 
The second gene to be assayed for was Nanog, which has also been identified as a key 
regulator of ES cell pluripotency (Chambers et al 2003, Mitsui et al 2003) as discussed in 
the section 1.4.  
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Figure 3.15 QPCR analyses of Nanog transcript levels expressed by ES cells grown on either 0.1% 
gelatin or 100µg/well dimeric FIII9-FIII10 in media that either, A. contained LIF or B lacked LIF.  
N = 6. 20,000 ES cells seeded/well. 
 
Similar to the trend observed with Oct-4 levels when grown on the FIII9-FIII10 dimer 
there is an increase in the number of nanog transcripts on day 3 compared to the gelatin 
controls. There are no major changes in nanog transcripts in gelatin grown ES cells on 
either day similar to the lack of change in Oct-4 transcripts in gelatin grown ES cells. ES 
cells grown in the absence of LIF showed no major alterations in transcript levels on ES 
cell grown on the two surfaces. There is a slight upregulation of nanog transcripts when 
grown on the FIII9-FIII10 dimer on day 3 compared to the gelatin controls but this does 
not reach signficance.  
 
 
The transcriptional profile of Ehox was then examined upon growing ES cells on gelatin or 
the FIII9-FIII10 dimer. Ehox is a gene that at present has been found in mouse but not 
human ES cells and is found in undifferentiated ES cells (Jackson et al 2002).  
 
 
 
 
 
Gelatin-D3Dimer-D3 Gelatin-D6Dimer-D6
0
100
200
300
400
500
600
700
800
900
1000
1100
Plate surface coating
ns
Gelatin-D3Dimer-D3 Gelatin-D6Dimer-D6
0
500
1000
1500
2000
2500
3000
3500
4000
4500
0.0057 P =
Plate surface coating  74 
 
 
 
 
 
 
A              B 
Figure 3.16 QPCR analyses of Ehox transcript  levels  expressed by  ES cells grown on either 0.1% 
gelatin or 100µg/ml dimeric FIII9-FIII10 in media that either A. contained LIF or B. lacked LIF. N = 
6. 20,000 ES cells/well.   
 
In the presence of LIF the levels of Ehox transcripts were unchanged as can be seen in 
figure 3.16 when grown on either the FIII9-FIII10 dimer or gelatin coated surfaces. There 
is a general increase in the levels of Ehox from day 3 to day 6 but there does not appear to 
be any difference between the ES cells grown on the FIII9-FIII10 dimer compared to ES 
cells grown on gelatin. Upon removal of LIF the levels of Ehox drop to very low levels in 
comparison  to  ES  cells  grown  in  the  presence  of  LIF,  almost  to  the  absolute  limit  of 
detection ability of the assay. The different surfaces that the ES cells are grown on do not 
appear to make any difference in terms of transcript level fluctuations. By day 6 the levels 
of Ehox are further reduced. This fits with the evidence that suggests Ehox is present in 
undifferentiated ES cells but is reduced upon the onset of differentiaton (Jackson et al 
2002). The QPCR data described so far is summarized in table 1 below. 
   In the presence  Absence of  In the presence  Absence of     
 of LIF     LIF    of LIF     LIF 
Gene   Day 3     Day 3    Day 6      Day 6 
 
Oct-4      Increased           Unchanged          Increased (ns)          Unchanged    
 
Nanog    Increased           Unchanged          Unchanged               Unchanged 
 
Ehox       Unchanged            Unchanged         Unchanged               Unchanged 
 
Table 1. Changes in the level of pluripotency gene’s transcript levels of ES cells grown on the FIII9-FIII10 
dimer compared to gelatin controls. 
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Brachyury is a gene expressed early during mesodermal differentiation of ES cells and is 
considered to be one of the earliest known markers of mesoderm differentiation (Herrmann 
et al 1990, Wilkinson et al 1990). Upon carrying out QPCR for this gene in the presence of 
LIF it was noted that the levels of Brachyury increased if grown on the FIII9-FIII10 dimer 
in comparison to gelatin grown ES cells. 
 
 
 
 
 
 
 
 
 
 
 
A              B 
Figure 3.17 QPCR analyses of Brachyury transcript levels expressed by ES cells grown on either 0.1% 
gelatin or 100µg/well dimeric FIII9-FIII10 in media that either, A. contained LIF or B. lacked LIF. N 
= 6. 20,000 ES cells/well.  
 
Rather surprisingly upon the removal of LIF the levels of Brachyury did not significantly 
alter when grown on either gelatin or the FIII9-FIII10 dimer. There is a very slight increase 
in transcript levels when grown on the FN dimer as opposed to gelatin controls on day 3 
but  this  does  not  reach  significance.  On  day  6  the  trend  is  the  opposite  with  a  slight 
increase  in  Brachyury  in  ES  cells  grown  on  gelatin  but  again  this  does  not  reach 
significance. 
 
 
With the transient upregulation of brachyury noted, several other genes with known roles 
in  mesodermal  differentiation  were  examined.  GATA-1  is  one  of  the  most  studied 
haematopoietic  transcription  factors  with  established  functions  in  erythroid  and 
megakaryocyte  development  (Orkin  1998).  It  is  apparent  that  in  either  in  presence  or 
absence  of  LIF  the  FIII9-FIII10  dimer  has  no  significant  effect  on  the  GATA-1 
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transcriptional profile of ES cells at these time points as figure 3.18 demonstrates. This 
leads us to believe that if there is any differentiation inducing properties of the FIII9-FIII10 
dimer it does not program ES cells to differentiate into erythroid/megakaryocyte lineages. 
It is also possible that the ES cells grown on the FIII9-FIII10 dimer may be differentiating 
into erythroid/megakaryocytic lineages but the time points chosen for this assay were too 
early to detect this 
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Figure 3.18 QPCR analyses of GATA-1 transcript levels expressed by ES cells grown on either 0.1% 
gelatin or 100µg/well dimeric FIII9-FIII10 in media that either, A. contained LIF or B. lacked LIF.  
N = 6. 20,000 ES cells/well. 
 
A marker of hemopoiesis (Bonnet 2002), CD34 was then assayed for. Quite strikingly, in 
the presence of LIF, growing ES cells upon the FIII9-FIII10 dimer significantly suppressed 
the number of transcripts generated when compared to gelatin grown ES cells as displayed 
in figure 3.19. This reduction in the transcriptional profile of CD34 is apparent on both day 
3 and day 6. Removal of LIF and growth on the various surfaces results in a consistent but 
non-significant increase in CD34 levels when grown on the FIII9-FIII10 dimer as opposed 
to gelatin grown ES cells. 
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Figure 3.19 QPCR analyses of CD34 transcript levels expressed by ES cells grown on either 0.1% 
gelatin or 100µg/well dimeric FIII9-FIII10 in media that either, A. contained LIF or B. lacked LIF. N 
= 6. 20,000 ES cells/well. 
 
 
SCL  is  a  transcription  factor  required  for  early  differentation  of  ES  cells  into 
haematopoietic stem cells (Lecuyer et al 2004, Park et al 2005). This gene was examined 
to look for any indications of differentiation into this lineage. In figure 3.20 there appears 
to be no changes in SCL transcripts when grown on either gelatin or the FIII9-FIII10 dimer 
in the presence or absence of LIF. There is a reduction in transcript numbers on day 6 in 
both gelatin grown and FIII9-FIII10 dimer grown ES cells in the presence or absence of 
LIF but again does not appear to be as a result of the plate surfaces. It is possible that this 
notable reduction in SCL levels on day 6 is due to the ES cells sensing confluency that 
alters their transcriptional profile. 
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Figure  3.20  QPCR  analyses  of  SCL  transcript  levels  expressed  by  ES  cells  grown  on  either  0.1% 
gelatin or 100µg/well dimeric FIII9-FIII10 in media that either, A. contained LIF or B. lacked LIF.  
N = 6. 20,000 ES cells/well. 
 
 
To look for any evidence of endothelial cell differentiation, Flk-1 a gene well known to be 
involved in the differentiation of ES cells into this lineage (Shalaby et al 1995, Shalaby et 
al 1997), was examined. ES cells grown on the FIII9-FIII10 dimer in either the presence or 
absence of LIF resulted in an increase in the number of transcripts that was reproducible 
but did not reach significance as shown in figure 3.21. 
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Figure 3.21 QPCR analyses of Flk-1 transcript levels expressed by ES cells grown on either 0.1% 
gelatin or 100µg/ml dimeric FIII9-FIII10 in media that either A. contained LIF or B. lacked LIF.  
N = 6. 20,000 ES cells/well. 
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In order to identify any possible role the FIII9-FIII10 dimer may have in the induction of 
cardiomyocyte differentiation, the gene NKX2.5 was assayed for. NKX2.5 is a 
transcription factor involved in the development of heart formation (Murry et al 2008) and 
would therefore be an indicator of the ability of the FIII9-FIII10 dimer to induce cardiac 
development. Figure 3.22 clearly shows that at the time points looked at there was no 
obvious effect on the levels of NKX2.5 when ES cells were grown on either the FIII9-
FIII10 dimer or gelatin. When LIF is removed there is a small increase in ES cells grown 
on the FIII9-FIII10 dimer although this increase is not significant. Secondly in the absence 
of LIF there is a sharp decrease in the levels of NKX2.5 in ES cells grown on both surfaces 
between day 3 and day 6. 
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Figure 3.22 QPCR analyses of NKX2.5 transcript levels expressed by ES cells grown on either 0.1% 
gelatin or 100µg/ml dimeric FIII9-FIII10 in media that either A. contained LIF or B. lacked LIF. N = 
6. 20,000 ES cells/well. 
 
 
Changes in mesodermal transcripts grown on FIII9-FIII10 dimer in comparison to gelatin 
control ES cells are shown in table 2. 
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  Presence  of 
LIF 
Presence  of 
LIF 
Absence  of 
LIF 
Absence  of 
LIF 
Gene  Day 3  Day 6  Day 3   Day 6 
Brachyury  Increased  Unchanged  Unchanged  Unchanged 
GATA-1  Unchanged  Unchanged  Unchanged  Unchanged 
CD34  Decreased  Decreased  Increased (ns)  Unchanged 
SCL  Unchanged  Unchanged  Unchanged  Unchanged 
Flk-1  Increased (ns)  Unchanged  Increased (ns)  Unchanged 
NKX2.5  Unchanged  Unchanged  Unchanged  Unchanged 
 
Table 2. Changes in the levels of mesodermal gene transcript levels of ES cells grown on the FIII9-FIII10 
dimer compared to gelatin controls. 
In order to look for indications that endodermal differentiation may be occurring, QPCR 
was carried out to look at the effect, if any, of the FIII9-FIII10 dimer on ES cell transcript 
levels  of  Foxa2.  This  gene  was  chosen  due  to  its  established  role  in  endodermal 
differentiation, often in conjunction with Sox17 (Kanai-Azuma et al 2002, Friedman and 
Kaestner 2006). Foxa2 is widely expressed in the definitive endoderm and in structures 
generated from the endoderm such as pancreas, liver and lung (Friedman and Kaestner 
2006). The results in figure 3.23 clearly show that Foxa2 does not have any role in the 
morphological changes initially observed either in the presence or absence of LIF. There is 
a general reduction in Foxa2 transcripts going from day 3 to day 6 although there is no 
difference between ES cells grown on the FIII9-FIII10 dimer and gelatin.  
 
 
 
 
 
 
 
 
A            B 
Figure 3.23 QPCR analyses of Foxa2 transcript levels expressed by ES cells grown on either 0.1% 
gelatin or 100µg/ml dimeric FIII9-FIII10 in media that either A. contained LIF or B. lacked LIF. 
 N = 6.  20,000 ES cells/well. 
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During this study we attempted to generate primers specific for Sox 17 but were unable to 
do so as the primers designed could not be optimized to bind specifically to the gene of 
interest. Instead multiple bands were observable upon carrying out electrophoresis of the 
RT-PCR products on an agarose gel then visualizing the bands through use of ethidium 
bromide  
 
 
In  order  to  look  for  some  evidence  of  ectodermal  differentiation,  neuro-ectodermal 
differentiation specific QPCR was used to examine whether the gene Nestin was affected 
by growth on the FIII9-FIII10 dimer compared with gelatin controls. Nestin is a gene 
expressed by neuroepithelial stem cells (Lendahl et al 1990) and today is a commonly used 
marker to identify neuro-ectodermal populations (Conti et al 2005).  
 
 
 
 
 
 
 
 
 
 
 
A              B 
Figure 3.24 QPCR analyses of Nestin transcript levels expressed by ES cells grown on either 0.1% 
gelatin or 100µg/ml dimeric FIII9-FIII10 in media that either A. contained LIF or B. lacked LIF. N = 
6. 20,000 ES cells/well. 
 
 
In the presence of LIF there is an increase in the levels of Nestin in ES cells grown on the 
FIII9-FIII10 dimer on day 3 compared to gelatin controls. There is then a subsequent down 
regulation of the levels of Nestin on day 6 compared to day 3. This down regualation of 
Nestin grown on the FIII9-FIII10 dimer from day 3 to 6 is similar to the down regulation 
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observed when Oct-4 and Brachyury were assayed for. In the absence of LIF there appears 
to be a very general increase in Nestin transcripts when moving from day 3 to day 6 
although this increase is not significant. However the FIII9-FIII10 dimer appears to play 
little role in this upregulation as the levels of Nestin transcripts are very similar when 
grown  on  either  gelatin  or  FIII9-FIII10  dimer.  The  results  of  the  final  two  assays 
examining for endodermal and ectodermal differentiation are described succinctly below. 
 
  Presence  of 
LIF 
Presence  of 
LIF 
Absence  of 
LIF 
Absence  of 
LIF 
Gene  Day 3  Day 6  Day 3   Day 6 
Foxa2  Unchanged  Unchanged  Unchanged  Unchanged 
Nestin  Increased  Unchanged  Unchanged  Unchanged 
Table 3. Changes in the levels of endodermal (Foxa2) and ectodermal (Nestin) gene transcript levels of ES 
cells grown on the FIII9-FIII10 dimer compared to gelatin controls. 
 
Based on the results of the QPCR assays there appeared to be some indications that the 
FIII9-FIII10 dimer may have some pro differentiation effects when ES cells were grown 
upon them in a monolayer. However, the Foetal Calf Serum (FCS) in ES cell complete 
media is known to contain factors that have some pro differentiation effects. In order to 
more closely examine any possible differentiation stimuli the FIII9-FIII10 dimer may be 
conferring to the ES cells, serum replacement media optimized for ES cell culture was 
used in place of complete FCS containing media.  
 
 
ES cells were seeded into six well plates coated with either gelatin or FIII9-FIII10 dimer, 
then  left  to  grow  in  the  absence  of  LIF.  It  was  thought  that  this would  optimize  any 
differentiation potential the FIII9-FIII10 dimer may have. In this assay additional time 
points were used and an undifferentiated control added in order to more closely study any 
early transcriptional changes that may occur when growing ES cells on either gelatin or the 
FIII9-FIII10 dimer. 
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Figure 3.25 QPCR analyses of ES cell pluripotency markers, A. Oct-4 B. Nanog C. Ehox transcripts 
expressed  by  ES  cells  grown  on  either  0.1%  gelatin  or  100µg/ml  dimeric  FIII9-FIII10  in  serum 
replacement medium. N = 3.  
 
In figure 3.25A the levels of Oct-4 are shown to drop upon removal of LIF when compared 
to undifferentiated ES cells but are found to persist at low but noticeable levels. This fits 
with previous observations that Oct-4 does remain at a low level in differentiating ES cells 
(Smith 2001). In contrast to observations using FCS medium in the presence of LIF there 
appears to be no real increase in the levels of Oct-4 when grown on the FIII9-FIII10 dimer 
as opposed to gelatin. There is a small increase in Oct-4 levels in ES cells grown on the 
FIII9-FIII10 dimer on day 6 but this does not reach significance.  
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The result observed in figure 3.25B was unexpected as, although there is an initial drop in 
Nanog levels as would be expected upon the removal of LIF (Chambers et al 2003), the 
levels of Nanog are found to recover and increase. This is particularly noted when ES cells 
are grown on the FIII9-FIII10 dimer. By day 8 the levels of Nanog generated by ES cells 
grown in a monolayer on the FIII9-FIII10 dimer have returned to the same level as those 
observed in the undifferentiated ES cell controls.  
 
 
Growth of ES cells in the absence of LIF, in serum free medium, on either gelatin or FIII9-
FIII10 dimer appears to have no direct effect on the levels of Ehox produced. There is a 
small increase followed by decrease in the levels of Ehox transcripts. This is followed by a 
substantial increase in the levels of Ehox on day 8. This result is in agreement with the 
initial  study  of  this  gene  (Jackson  et  al  2002).  The  results  of  the  assays  looking  at 
pluripotency markers using serum replacement media are summarized below.  
 
Gene  General pattern of 
transcriptional profile 
Specific effect of FIII9-FIII10 dimer 
compared to gelatin controls 
Oct-4  Steady down 
regulation. 
No effect. 
Nanog  Initial down 
regulation, followed 
by steady up 
regulation to levels 
similar to those 
observed in 
undifferentiated 
controls. 
Slightly higher transcript levels observed 
although not significant. 
 
Ehox 
 
Low levels initially, 
with the levels of 
transcripts increasing 
several fold on the last 
time point. 
 
No effect. 
 
Table 4. Changes in the levels of pluripotency gene transcript levels of ES cells grown on the FIII9-FIII10 
dimer compared to gelatin controls. 
 
The  various  genes  used  to  analyze  whether  the  FIII9-FIII10  dimer  induces  ES  cell 
differentiation into any one particular cell lineage/cell type(s) using serum replacement 
medium were then assayed for.   85 
 
   
 
 
 
 
 
 
 
 
 
 
 
A                                                            B         
Figure 3.26 QPCR analyses of, A. Foxa2 B. Brachyury transcripts expressed by ES cells grown on 
either 0.1% gelatin or 100µg/ml dimeric FIII9-FIII10 in serum replacement medium. N = 3.  
 
 
In figure 3.26A it is clear that the FIII9-FIII10 dimer has some effect on the levels of 
Foxa2 transcripts. After two days of growth in serum replacement medium in the absence 
of LIF there is a transient and significant upregulation in Foxa2 transcripts produced by ES 
cells grown on the FIII9-FIII10 dimer as opposed to gelatin controls. At every other time 
point the opposite is observed with a lower level of Foxa2 transcripts generated by ES cells 
on  the  FIII9-FIII10  dimer  compared  to  gelatin  grown  ES  cells.  Upon  assaying  for 
Brachyury an up regulation was observed in ES cells grown on the FIII9-FIII10 dimer 
compared to gelatin grown ES cells on days 2 and 4 although this increase does not reach 
significance. On day 6 there is no observable difference in the transcripts produced by ES 
cells on either surface and on day 8 there is a reduction in the level of transcripts produced 
by FIII9-FIII10 dimer grown ES cells when compared to gelatin grown ES cells. This 
again does not reach significance. 
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A                                                            B         
Figure 3.27 QPCR analyses of, A. NKX2.5 B. Nestin transcripts expressed by ES cells grown on either 
0.1% gelatin or 100µg/ml dimeric FIII9-FIII10 in serum replacement medium. N = 3.  
 
 
Growth of ES cells on the FIII9-FIII10 dimer appears to have a significant effect on both 
the levels of NKX2.5 and Nestin transcripts as upregulation of both are limited upon 
growth on the FIII9-FIII10 dimer when compared to gelatin grown ES cells controls. The 
FIII9-FIII10 dimer affects the level of Nestin transcripts earlier than NKX2.5. Nestin 
upregulation is limited on day 4 on the FIII9-FIII10 dimer whereas NKX2.5 shows initial 
signs of inhibition on day 6. 
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C 
Figure 3.28 QPCR analyses of, A. Flk-1 B. CD34 C. SCL transcripts expressed by ES cells grown on 
either 0.1% gelatin or 100µg/ml dimeric FIII9-FIII10 in serum replacement medium. N = 3.  
 
 
From figure 3.28A we can say with reasonable confidence that neither the FIII9-FIII10 
dimer nor gelatin has any discernable role in the induction of a FLK-1 positive population 
of ES cells. There is a general reduction in the levels of FLK-1 transcripts upon removal of 
LIF. There also appears to be no effect of the FIII9-FIII10 dimer on CD34 transcripts as no 
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real trend appears here.  Finally the levels of SCL appear unaffected by the growth of ES 
cells on either gelatin controls or the FIII9-FIII10 dimer. There is a considerable reduction 
in SCL transcripts upon removal of LIF but no difference occurs between the two surfaces 
in the absence of LIF. The data observed during the QPCR assays carried out to look for 
differentiation of ES cells are summarized in table 5 below. 
   
Gene 
 
 
General pattern of 
transcriptional profie 
Specific effect of FIII9-FIII10 dimer 
compared to gelatin controls 
Foxa2  Initial down regulation 
compared to 
undifferentiated ES cell 
controls. Followed by up 
regulation of transcripts 
Significant increase in transcripts on 
day 2, followed by a reduction in the 
level of transcripts on days 4, 6, and 
8. Days 4 and 8 show significant 
down regulation. 
Brachyury  No obvious pattern  Increased levels of Brachyury 
transcripts on days 2 and 4 but does 
not reach significance. A reduction in 
the transcripts on day 8 but again is 
not significant. 
NKX2.5  No change initially in 
the levels of transcripts 
compared to ES cell 
controls. Followed by 
changes depending on 
the plate surface coating. 
Significant reduction in transcripts on 
days 6 and 8. 
Nestin  No change initially in 
the levels of transcripts 
compared to ES cell 
controls. Followed by 
changes depending on 
the plate surface coating. 
Significant reduction in transcripts on 
days 4, 6 and 8. 
Flk-1  General reduction in 
transcript levels. 
No significant effect. 
CD34  No real pattern, slight 
overall reduction in 
transcript numbers 
compared to 
undifferentiated ES cell 
controls. 
No significant effect. 
 
 
 
SCL 
Several fold reduction in 
transcript levels 
compared to 
undifferentiated ES cell 
controls. 
No significant effect. 
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Table 5. Changes in the markers of differentiation gene transcript levels of ES cells grown on the FIII9-
FIII10 dimer compared to gelatin controls. 
Chapter 4 Discussion 
 
4.1. Cell adhesive properties  of the FIII9-FIII10 derivatives 
 
The data presented in figure 3.1 indicated that there was a negligible effect on the cell 
attachment potential of FIII9-FIII10 derivatives when the protein is displayed in a specific 
orientated conformation. Although there appeared to be a small increase in the number of 
colonies formed when orientated 2-D polyvalent displays are used there was no significant 
difference  compared  to  using  FIII9-FIII10  surfaces  furnished  in  a  random  manner. 
Although there are studies suggesting that factors such as the clustering and concentration 
of ligands are required to optimize cell adhesion (Maheshwari et al 2000, Koo et al 2002, 
Irvine  et  al  2002,  Kreiner  et  al 2008)  the  data presented  in  figure  3.1  show  quite  the 
opposite.  It  is  possible  that  the  specific  conformation  of  ligands  could  enhance  cell 
adhesion of specific cell lines such as BHK fibroblasts used in Kreiner et al 2008 and that 
the lack of effect observed in this study was specific to ES cells. It is unlikely however that 
the generation of 2-D polyvalent displays is in any way an advantage to the growth of ES 
cells in monoculture and therefore this was removed from the remainder of the project 
 
 
As stated earlier in the results section there were a number of interesting results come came 
out of the experiment presented in figure 3.1. The FIII9-FIII10 dimer had a greater ability 
to support ES cell colonies than gelatin, a commonly used surface for the culturing of ES 
cells. Therefore it is possible that these FIII9-FIII10 derivatives would be of potential use 
as a surface medium for ES cell culture. The second and more intriguing observation was 
the phenotypic changes observed upon culturing ES cells on FIII9-FIII10 derivatives as 
opposed to gelatin as shown in figure 3.2. ES cells grown on gelatin tended to from small 
round colonies whereas ES cells grown on the FIII9-FIII10 derivatives were predominantly 
flatter and more spread in morphology. 
 
 
This difference in the morphology of ES cells grown on the FIII9-FIII10 derivatives as 
compared with those grown on gelatin was of interest as there is some literature suggesting   90 
that ES cells grown on Fibronectin in a monolayer tend to flatten out and differentiate 
(Nishikawa et al 1998, Ying et al 2003, Hayashi et al 2008). With the majority of work 
carried out on delineating the mechanisms of ES cell differentiation using embryoid bodies 
the use of monolayer ES cells could be an alternative method of ES cell differentiation. 
Indeed there is evidence that ES cell differentiation along certain lineages proceeds more 
efficiently in monolayers as opposed to embryoid bodies (Nishikawa et al 1998). What 
made  this  change  in  morphology  all  the  more  interesting  is  that  these  ES  cells  were 
cultured in complete medium containing 1000U/ml of LIF. Even though LIF is essential 
for the maintenance of ES cells in an undifferentiated state (Smith et al 1998, Williams et 
al 1998) there appeared to be partial differentiation of the ES cells grown on the FIII9-
FIII10 dimer. 
 
 
4.2. Optimal conformation of FIII9-FIII10 derivatives for ES cell adhesion 
 
The fact that the dimeric form of the FIII9-FIII10 derivative had the greatest ability to 
support the growth of ES cell colonies was an unexpected finding when you consider that 
one molecule of the dimer will have a smaller number of the FIII9-FIII10 adhesive sites 
compared to the trimer or tetramer which will have 3 and 4 FIII9-FIII10 adhesive sites per 
molecule respectively. The experiment shown in figure 3.3 and confirmed by the cloning 
efficiency  experiment  in  figure  3.4  showed  that  the  FIII9-FIII10  derivative,  which 
consistently achieved the highest levels of ES cell colony formation, was the dimer.  
 
 
It is reasonable to hypothesize that the dimeric form presents the FIII9-FIII10 adhesive 
sites  in  a  manner  that  enables  the  ES  cells  to  more  easily  interact  with  them  and 
subsequently bind. It must be stressed however that although the dimeric form of the FIII9-
FIII10 derivative is consistently more efficient at ES cell adhesion compared to the other 
conformations they are not statistically significant. Therefore the difference is marginal but 
consistent. This result goes against a previous report by our collaborators suggesting that 
the tetrameric form of the FN derivative was the most efficient at adhering cells (Kreiner et 
al 2008). However in the report by Kreiner et al 2008 BHK fibroblasts were used in the 
cell adhesion assays. It is possible that the reason our results differ from that of Van der 
Walle and colleagues (Kreiner et al 2008) was simply due to the fact that different cell   91 
lines were used. The two studies do agree however that there is no one conformation of the 
FIII9-FIII10 derivative that is statistically the most efficient at cell adhesion.  
 
 
4.3. Effect of FIII9-FIII10 derivatives on ES cell proliferation 
 
The lack of any discernable effect on proliferation of ES cells upon growth on the FIII9-
FIII10  derivatives  in  comparison  to  gelatin  grown  ES  cells  is  no  surprise  as  it  is  in 
agreement  with  the  study  carried  out  by  Hayashi  et  al  2007.  It  is  interesting  to  note 
however that in the report by Hayashi et al 2007, the growth curve observed is gradual 
whereas figure 3.5 in the current study shows a marked increase in cell numbers between 
days 3 and 4. The result by Hayashi et al 2007 are perhaps at odds with the literature as ES 
cells are well known for their ability to proliferate and expand when in controlled culture 
conditions (Smith et al 2001). This rapid increase in cell numbers is the reason that close 
monitoring of ES cell cultures and regular cutting back of cell numbers is required to 
maintain ES cells in a pluripotent state (Smith et al 2001). Upon plating of ES cells one 
would  expect  a  period  of  cell  attachment  where  there  is  a  minimal  increase  in  cell 
numbers. As ES cells become accustomed to their environment an increase in cell numbers 
would then be expected to occur as observed in this study. Although whole FN was used in 
the study by Hayashi et al 2007 it is unlikely that this would be a factor contributing to the 
differences in result when both studies are compared. 
 
 
4.4. Comparison of the adhesive abilities of the dimeric FIII9-FIII10 with whole FN 
 
It was not surprising to see that when used at equal microgram concentrations the FIII9-
FIII10 dimer had far superior cell attachment abilities compared with whole FN. When one 
considers that whole FN has a molecular weight of between 440-500kDA and the FIII9-
FIII10  dimer’s  molecular  weight  is  only  29.7kDA,  if  used  at  the  same  quantity  in 
micrograms there would be a far larger number of FIII9-FIII10 adhesive sites in 50µg of 
the FIII9-FIII10 dimer than in whole FN.  
 
However this experiment was important as if the FIII9-FIII10 dimer has a greater potential 
to support ES cell colony formation compared with whole FN at the same concentration   92 
this would be a good argument for its use instead of whole FN for basic cell adhesion and 
for the reasons stated in the results section. 
 
 
 The ability of the FIII9-FIII10 dimer and whole FN to support ES cell colonies was then 
examined with both proteins used at an equal mole for mole concentration. This simply 
means that the same number of FIII9-FIII10 binding sites would be found in six well plates 
coated with either the FIII9-FIII10 dimer or whole FN. One might expect that if the same 
numbers of binding sites were available, a similar number of ES cel colonies would form. 
Interestingly this was not seen upon plating the proteins in this manner, and whole FN was 
statistically more efficient at supporting the growth of ES cell colonies compared with the 
FIII9-FIII10 dimer as shown below in figure 3.7. 
 
 
This trend is consistent when the numbers of ES cell colonies are examined at day 3 using 
the colony counting technique and is in agreement with the cloning efficiency data. Whilst 
of intellectual value this result was again not totally unexpected. The FIII9-FIII10 dimer is 
designed to bind with high affinity to the α5β1 integrin receptor but whole FN can bind to 
multiple  integrin  receptors  including  α3β1,  α4β1,  α5β1,  α8β1,  αvβ1,  αvβ3,  αvβ6  and 
αIIbβ3 and all of these have been identified on ES cells (Yang JT et al 1999). Although the 
α5β1 integrin receptor appears to be the primary receptor for interaction with FN (or at 
least the best studied) it would not be a surprise if the additive effect of whole FN binding 
to multiple integrin receptors would enhance its ES cell binding ability when both proteins 
are used at equal molar concentrations. 
 
 
 Secondly the FIII9-FIII10 dimer may not be a perfect mimic of FN found in the ECM, 
which intact FN more closely resembles. This is a logical suggestion as the derivatives are 
only a small peptide fragment of the whole protein. Finally the cell binding domain may be 
more stable when found in the context of the whole protein and may have a preferred 
orientation  upon  absorption  to  plastic  surfaces  for  integrin  binding.  All  of  these 
possibilities  could  explain  the  results  observed.  However  the  pharmaceutical  industry 
would have to justify the costs and the purity of manufacturing whole FN instead of using   93 
the  FIII9-FIII10  dimer.  There  is  no  doubt  that  these  FIII9-FIII10  dimers  have  some 
potential uses for basic cell attachment purposes. 
 
 
4.5. Effect of LIF titration on ES cell morphology 
 
The  change  in  morphology  of  ES  cells  grown  on  the  FIII9-FIII10  dimer  when  the 
concentration of LIF was increased, i.e. from a dispersed phenotype to a tight phenotype 
was an indication that something may be going on at the molecular level. It is possible that 
when ES cells were adhering to the FIII9-FIII10 dimer they were being given signals to 
start to differentiate even in the presence of LIF. The presence of LIF in this situation 
would  inhibit  any  differentiation  of  the  ES  cells  although  due  to  the  potential  pro-
differentiation signals being received by the cells from the FIII9-FIII10 dimer there is an 
initial morphological change. However as the concentration of LIF was increased this pro 
differentiation signal was further subdued and the ES cells reverted to a phenotype more 
similar to that seen when ES cells are grown on gelatin plates. It is clear from figure 3.10 
that the titration of LIF did have an effect on these “tight” and “dispersed” colonies as the 
ratios of both colony types clearly change as the cytokine is increased in concentration. It 
would have been interesting to carry out QPCR analysis of ES cells grown on the FIII9-
FIII10 dimer in the presence of increasing concentrations of LIF to look for any changes in 
transcript  levels  that  could  be  responsible  for  the  observed  change  in  morphology. 
However it was felt at the time that to repeat this experiment would be too expensive in 
terms of the use of LIF to justify carrying out. 
 
 
4.6. Alkaline phosphatase staining 
 
The  use  of  the  alkaline  phosphatase  assay  provided  strong  evidence  that  while  there 
appeared to be morphological changes occurring on ES cells grown in a monolayer on the 
FIII9-FIII10  dimer,  these  cells  in  the  presence  of  LIF  were  maintaining  their 
undifferentiated, pluripotent state. It was clear that any pro-differentiation signals the ES 
cells may have been receiving from the FIII9-FIII10 dimer were being inhibited by LIF 
signalling via the gp130 receptor chain. Upon removal of LIF the expected loss of the 
majority  of  alkaline  phosphatase  staining  occurred.  There  was  no  obvious  difference   94 
between ES cells cultured in the absence of LIF grown on either gelatin or the FIII9-FIII10 
dimer. Any effect the FIII9-FIII10 dimer had on ES cell differentiation did not result in 
any marked reduction in alkaline phosphatase activity compared with ES cells grown on 
gelatin. 
 
 
4.7. Transcriptional analysis in the presence and absence of LIF in serum containing media  
 
The transient increase in Oct-4 levels was of interest as a publication from Austin Smith’s 
laboratory elegantly showed that if Oct-4 expression was increased by just under two fold 
it resulted in the production of an early endodermal/mesodermal population of cells (Niwa 
et al 2000). It must be stated clearly at this point however that transcriptional changes are 
merely an indicator as to what may be going on and one cannot draw strong conclusions 
from  them.  Therefore  it  is  possible  that  this  upregulation  of  Oct-4  could result  in  the 
formation of an early mesodermal/endodermal population but protein expression studies 
would have to be carried out in order to confirm such a hypothesis. On day 6 the increased 
levels of Oct-4 transcripts observed on day 3 had reduced to the levels of ES cells grown 
on gelatin. It should also be noted that ES cells grown on gelatin maintain their levels of 
Oct-4 with no real increase or decrease in transcript numbers which is an indication that 
these ES cells remain essentially undifferentiated.  
 
 
 Upon growth of ES cells on the two surfaces in the absence of LIF a similar trend is 
observed in that there is an increase in transcript numbers on day 3 in ES cells grown on 
the FIII9-FIII10 dimer compared to gelatin. However, it should be noted that although this 
increase is consistent it does not reach significance (P = 0.0556). Similarly to ES cells 
grown in the presence of LIF there is a no real increase in numbers of Oct-4 transcripts in 
ES cells grown on gelatin in the absence of LIF. It should be remembered however that 
although  there  is  an  increase  in  Oct-4  transcripts,  which  may  indicate  a  possible 
mesodermal/endodermal population forming, the ES cells grown on the FIII9-FIII10 dimer 
remain undifferentiated as shown by the alkaline phosphatase study in figure 3.11. 
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This increase in Oct-4 transcript numbers was an indication that the FIII9-FIII10 dimer did 
indeed have some ES cell differentiation inducing properties. It should be remembered 
however  that  in  the  presence  of  LIF  ES  cells  maintain  their  pluripotent  state  as  seen 
through the alkaline phosphatase positivity of the colonies in figure 3.12. even though 
there is an increase in Oct-4 levels. As an increase in Oct-4 levels is suggestive of ES cell 
differentiation into the mesodermal/endodermal lineages we looked for other markers that 
might provide further evidence that the FIII9-FIII10 dimer were attempting to push ES 
cells down this lineage. The upregulation of Brachyury in ES cells grown on the FIII9-
FIII10 dimer at day 3 in the presence of LIF was further evidence indicating that ES cells 
grown on the FIII9-FIII10 dimer were trying to differentiate into an early mesodermal 
population.  
 
 
When LIF is removed and the ES cells allowed to differentiate on either gelatin or FIII9-
FIII10 dimer coated surfaces there is a small increase in Brachyury levels when grown on 
the FIII9-FIII10 dimer although this is not significant. Similar to the levels of Oct-4 the 
elevated levels of Brachyury transcripts observed on day 3 induced by the FIII9-FIII10 
dimer are reduced to levels very similar to those observed on gelatin on day 6. These 
results suggest that there may be some mesodermal inducing properties of the FIII9-FIII10 
dimer  but  in  the  presence  of  LIF  the  ES  cells  are  maintaining  their  undifferentiated 
phenotype in spite of the transcriptional fluctuations observed. On day 6 in the absence of 
LIF there is a decrease in the levels of Brachyury observed in ES cells grown on the FIII9-
FIII10  dimer.  This  is  perhaps  strange  when  one  considers  the  enhanced  levels  of 
Brachyury observed in ES cells grown on the FIII9-FIII10 dimer on day 3 in the presence 
of LIF. Though it is merely speculation it is possible that in the absence of LIF ES cells 
grown on the FIII9-FIIII10 dimer increase the levels of Brachyury as early as 1 or 2 days 
after plating and what we are seeing on day 3 are the levels of Brachyury decreasing as the 
signal to differentiate into an early mesodermal population has been received by the cell.  
 
 
Concomitant with the increase in levels of Oct-4 and Brachyury there is also an increase in 
the  levels  of  Nanog  on  day  3  when  grown  in  the  presence  of  LIF.  It  is  perhaps  not 
surprising  that  Nanog  up  regulates  in  ES  cells  grown  upon  the  FIII9-FIII10  dimer  as 
Nanog is known for its ability to reverse the differentiation of ES cells and return the cells   96 
to an undifferentiated state if grown in the presence of LIF (Suzuki et al 2006a, Suzuki et 
al 2006b). The studies carried out by Belmonte and colleagues (Suzuki et al 2006a, Suzuki 
et  al  2006b)  demonstrated  that  ES  cells  stimulated  to  differentiate  using  bone 
morphogenetic proteins (BMPs) resulted in the upregulation of Brachyury which occurred 
in tandem with an upregulation of Nanog. This dual up-regulation of Nanog and Brachyury 
has been noted in this study with the difference in stimulating this upregulation being the 
use of a peptide of FN, which binds with high affinity to α5β1 integrin receptor (van der 
Walle et al 2002). 
 
 
 Belmonte and co-workers then identified that STAT3 and Brachyury would bind to an 
element involved in the regulation of Nanog that resulted in elevated levels of Nanog to 
counteract the pro-differentiation effects of BMPs (Suzuki et al 2006b). Importantly in 
2007, Austin Smith’s group showed that one of the major functions of Nanog was to 
maintain ES cell pluripotency by preventing the upregulation of pro-differentiation genes 
(Chambers et al 2007). It is possible that growth of ES cells on the FIII9-FIII10 dimer 
signals  ES  cells  to  begin  differentiating  but  in  the  presence  of  STAT3  mediated  LIF 
signalling  results  in  the  upregulation  of  Nanog,  which  reverses  the  pro-differentiation 
effects of the FIII9-FIII10 dimer. This reversal of ES cell differentiation is confirmed in 
the high percentage of alkaline phosphatase staining observed when ES cells are grown on 
the FIII9-FIII10 dimer in the presence of LIF.  
 
 
If this co upregulation of Brachyury and Nanog in ES cells grown on FIII9-FIII10 dimer in 
the presence of LIF had been identified earlier in the project it would have been of interest 
to use small interfering RNA (siRNA) to partially inhibit Nanog and observe whether the 
FIII9-FIII10  dimer  could  maintain  elevated  levels  of  Brachyury  and  induce  ES  cell 
differentiation.  Inhibiting  the  function  of  Nanog  completely  would  not  be  desirable 
however as this would result in the formation of an endoderm population (Mitsui et al 
2003)  regardless  of  the  potential  effects  of  the  FIII9-FIII10  dimer.  In  addition,  over 
expression  of  Nanog  in  ES  cells  then  growing  them  on  the  FIII9-FIII10  dimer  with 
subsequent monitoring of the levels of Brachyury would also be of interest. It is possible 
that  over  expressing  Nanog  could  inhibit  the  transient  increase  in  Brachyury  levels   97 
normally observed on day 3 in ES cells grown on FIII9-FIII10 dimer in the presence of 
LIF.  
 
 
It is clear that growing ES cells either on gelatin or the FIII9-FIII10 dimer in the presence 
of LIF does not alter Ehox. There are no major changes in the levels of Ehox regardless of 
the substrate grown on with the exception of a general increase in the levels of Ehox on 
day 6 as opposed to day 3. This increase in the levels of Ehox is not significant therefore 
the levels of Ehox in this setting are clearly maintained. Upon removal of LIF there is a 
general reduction of the levels of Ehox. This is in agreement with Jackson et al 2002 who 
identified that Ehox is expressed in undifferentiated ES cells and upon the induction of 
differentiation is reduced. This paper then goes on to state that the levels of Ehox begin to 
increase again several fold as differentiation continues. It is possible this increase is not 
observed as the assay is not carried out over a sufficiently long period of time. However 
this effect is observed later in this study using serum replacement media with additional, 
later time points. 
 
 
It appears that the haematopoietic transcription factor GATA-1 (Orkin 1998) is not altered 
upon growth of ES cells on either the FIII9-FIII10 dimer or the gelatin controls in the 
presence of LIF. There is an increase from day 3 to day 6 but there are no changes between 
surfaces. Removal of LIF does not appear to alter the lack of effect of the FIII9-FIII10 
dimer has on ES cell differentiation compared with the gelatin controls as though there is a 
general reduction in the levels of GATA-1, this occurs both in the gelatin control and 
FIII9-FIII10 dimer grown cells. Therefore it appears, certainly at the time points examined, 
that  these  ES  cells  are  not  being  induced  to  differentiate  into  the 
erythrocyte/megakaryocyte lineage due to the general reduction in the levels of GATA-1. 
It is possible that this is due to the growth of the ES cells in a monolayer. Secondly the 
time  points  used  may  be  too  early  to  observe  any  changes  in  GATA-1  that  could  be 
evidence of erythrocyte/megakaryocyte differentiation. 
 
 
Possibly the most surprising result obtained during the course of this study was the marked 
reduction in the level of CD34 upon growth of ES cells on the FIII9-FIII10 dimer in the   98 
presence of LIF compared to gelatin controls. As can be seen from figure 3.19, the levels 
of CD34 transcripts increase from day 3 to day 6 on gelatin, in contrast to ES cells grown 
on the FIII9-FIII10 dimer in which there is a significant reduction (P = 0.0003) in the 
number of CD34 transcripts from day 3 to day 6. The reason for this is unknown. It is 
possible  that  the  presence  of  STAT3  mediated  LIF  signaling,  in  addition  to  signals 
generated via the FIII9-FIII10 dimer binding to the α5β1 integrin receptor, results in a 
signaling cascade that reduces the levels of CD34. Further study would be required to 
identify why this peculiar result has occurred. 
 
 
  Upon removal of LIF there is a non significant increase in the levels of CD34 in ES cells 
grown on the FIII9-FIII10 dimer compared to gelatin controls. It is perhaps strange that 
this would occur as growth of ES cells on the FIII9-FIII10 dimer in the presence of LIF 
resulted  in  a  marked  reduction  in  the  levels  of  CD34.  One  possibility  is  that  the 
combination of signals from LIF signaling via the LIF receptor and the FIII9-FIII10 dimer 
signaling via the α5β1 integrin receptor results in a down regulation of CD34. However in 
the absence of LIF receptor signaling, the interaction of the FIII9-FIII10 dimer with the 
α5β1 intgrin receptor results in an up regulation of CD34 transcripts. 
 
 
Upon assaying for changes in the transcriptional levels of SCL, another transcription factor 
involved in haematopoesis (Lecuyer et al 2004, Park et al 2005) it was found that there was 
no obvious effect of the FIII9-FIII10 dimer on the levels of SCL. However there was a 
significant reduction (P<0.02) in the levels of SCL on day 6 compared to day 3 in ES cells 
grown on both surfaces in the presence of LIF. In the absence of LIF the trend is the same 
with a notable reduction in SCL transcripts from day 3 to day 6. This does not reach 
significance but is a consistent finding. One explanation of this marked reduction in the 
levels of SCL on day 6 is that SCL could be sensitive to approaching confluency. In this 
assay, on day 6, ES cells are approximately 70%-80% confluent and it is possible that this 
effects the levels of SCL. 
 
   99 
Analysis of the effect of growing ES cells on the FIII9-FIII10 dimer revealed that in the 
presence or absence of LIF there was a consistent, non-significant increase in the levels of 
Flk-1  transcripts.  The  levels  of  Flk-1  in  ES  cells  grown  on  gelatin  did  not  alter 
substantially on day 3 or 6 whether LIF was present or absent indicating that at least at 
these time points there appeared to be little in the way of gelatin inducing a Flk-1 positive 
population  of  cells. Initially  the  possibility  that the  FIII9-FIII10  dimer  may  be  a  mild 
inducer of endothelial cell differentiation, which Flk-1 is known to have a role in (Shalaby 
et al 1997) was considered. Although the fact that the increase in Flk-1 transcripts is not 
significant suggests that it might not be biologically important.  
 
 
The observed increase in the levels of Nestin was intriguing as it indicated that the FIII9-
FIII10 dimer may have some ectodermal inducing properties. This result is in agreement 
with another publication also investigating the effects of FN on ES cell function (Hayashi 
et al 2007). The publication by Ashashima and colleagues however reports a less than 0.5 
fold  increase  in  Fgf5  transcripts  (primitive  ectoderm  marker)  as  evidence  for  this.  In 
addition they state that ES cells grown in serum free medium in the presence of LIF have 
substantially reduced alkaline phosphatase levels when compared to gelatin controls. This 
result is not surprising as Austin Smith’s group previously showed that serum free cultures 
of ES cells cannot maintain their pluripotent identity even in the presence of LIF (Ying et 
al  2003)  and  begin  neural  differentiation.  This  paper  showed  that  it  was  bone 
morphogenetic proteins (BMPs), found in the serum that acted in concert with LIF to 
maintain the pluripotent state of ES cells (Ying et al 2003). Therefore the results from 
Ashashima and colleagues do not definitively confirm that it is the effect of the fibronectin 
on the ES cells, not simply the removal of BMPs from the media, that is causing the neural 
differentiation phenotype. 
From the QPCR results shown in figure 3.22 it appears that FIII9-FIII10 dimer plays no 
observable  role  in  either  elevating  or  decreasing  NKX2.5  transcripts  as  there  is  no 
difference between ES cells grown on gelatin or the FIII9-FIII10 dimer on day 6. The 
levels of NKX2.5 are elevated very slightly when moving from day 3 to day 6 but this is 
not  due  to  the  surfaces  the  ES  cells  are  grown  on.  In  the  absence  of  LIF  there  is  a 
substantial decrease in the levels of NKX2.5 on either gelatin or the FIII9-FIII10 dimer. 
The reduction of NKX2.5 transcripts in the absence of LIF was at odds with conventional 
wisdom, as ES cells  are well known to differentiate into cardiomyocytes when LIF is   100 
removed. However this occurs when ES cells are differentiated as embryoid bodies, the in 
vitro version of the embryo. It is possible that when plated on a monolayer ES cells do not 
have the capacity to form cardiomyocyte populations and therefore do not up regulate 
NKX2.5. 
 
 
There  was  no  identifiable  effect  of  the  FIII9-FIII10  dimer  on  the  levels  of  Foxa2,  an 
endodermal marker. When ES cells were plated on either gelatin controls or the FIII9-
FIII10 dimer no real differences were observed in the presence or absence of LIF. In 
addition the levels of Foxa2 dropped in both conditions suggesting that whatever the effect 
of the FIII9-FIII10 dimer was, it did not involve the gene Foxa2, At least not at these time 
points.  
 
 
4.8. Transcriptional analysis using serum replacement media 
 
As stated in the results section, the presence of potential differentiating agents in the media 
led to the use of serum replacement media in place of foetal calf serum complete media. 
Removal of LIF and growth of ES cells on either gelatin or the FIII9-FIII10 dimer led to a 
gradual  reduction  in  the  levels  of  Oct-4  in  serum  replacement  media.  There  was  an 
increase in the levels of Oct-4 on day 6 when ES cells were grown on the FIII9-FIII10 
dimer but this did not reach significance. This calls into question whether or not there is a 
mesodermal/endodermal inducing quality of the FIII9-FIII10 dimer as previously thought 
when significant increases in the levels of Oct-4 were observed in ES cells grown on the 
FIII9-FIII10 dimer in the presence of LIF. This assay is informative however as it clearly 
shows that the ES cells are differentiating as there is a gradual reduction of Oct-4 although 
the levels of Oct-4 do remain at a low level as has been previously documented when LIF 
is removed (Smith AG 2001). 
 
 
It is clear that growth of ES cells on the FIII9-FIII10 dimer in no way affects the levels of 
Ehox as no differences were observed between ES cells grown on gelatin or the FIII9-
FIII10 dimer. The changes observed in the levels of Ehox between time points however are 
in agreement with the initial report describing the identification of this gene (Jackson et al   101 
2002). Graham and colleagues (Jackson et al 2002) used embryoid bodies to show that low 
levels of Ehox are observed in undifferentiated ES cells but these levels increase five fold 
as  the  bodies  differentiate  further.  In  the  assay  detailed  in  figure  3.25C  the  levels  of 
transcripts up regulate on day 8 to levels similar to those observed by Jackson et al 2002.  
This result is interesting from another point of view as it appears that, at least in terms of 
early  transcriptional  events,  growing  ES  cells  on  a  monolayer  could  be  used  as  an 
alternative to embryoid bodies. The gene expression profiles are similar to that observed 
by Jackson et al 2002 with the only real difference in that the up regulation of Ehox occurs 
two days later using the monlayer approach. 
 
 
The reduction in the level of Nanog transcripts on both surfaces in serum replacement 
medium was to be expected as ES cells are known to lose Nanog expression upon culturing 
in the absence of LIF (Chambers et al 2003). Rather surprisingly it was noted that from day 
4 onwards the levels of Nanog began to increase on both surfaces. It is possible that, in the 
absence  of  LIF,  Nanog  transcripts  are  up  regulated  in  an  attempt  to  resist  ES  cell 
differentiation but in the absence of STAT3 mediated LIF signaling, functional Nanog 
protein cannot be produced therefore ES cell differentiation continues uninhibited. This is 
a possibility as Nanog and STAT3 signalling have been reported to act in concert to inhibit 
differentiation (Torres et al 2008). 
 
 
The increase in the levels of Foxa2 transcribed by ES cells grown on the FIII9-FIII10 
dimer  compared  with  gelatin  controls  cultured  in  serum  replacement  medium  is  an 
indication that the ES cells could be receiving an endodermal/mesodermal differentiation 
signal.  It  should  be  noted  that  the  levels  of  Foxa2  grown  on  the  FIII9-FIII10  dimer 
intitially increase on day 2, then reduce notably on day 4. The levels of Foxa2 transcripts 
then steadily rise on day 6 and day 8. The levels of Foxa2 are static between days 2 and 4 
when ES cells were grown on gelatin. The levels then begin to rise on days 6 and 8. As ES 
cells are known to differentiate into all 3 germ layers in the absence of LIF (Smith 2001) it 
is possible that the FIII9-FIII10 dimer gives the ES cells an earlier, perhaps more specific 
signal to differentiate into this particular lineage. 
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Although the levels of Brachyury do increase in ES cells grown on the FIII9-FIII10 dimer 
on days 2 and 4 this does not reach significance, indicating that although Brachyury may 
play a role in the effects observed through use of the FIII9-FIII10 dimer it may not be the 
primary gene involved. This is at odds with ES cells grown in the presence of LIF in 
complete media on the FIII9-FIII10 dimer when a significant increase in the levels of 
Brachyury was noted earlier in the results. It is possible that in the absence of LIF using 
serum replacement medium reduces the impact of Brachyury on this process. Secondly in 
the serum replacement assay a day 3 time point was not used which may have shown 
significant up regulation of Brachyury as observed in ES cells grown on the FIII9-FIII10 
dimer.  
 
 
It is apparent that the FIII9-FIII10 dimer inhibits the differentiaton of ES cells into certain 
lineages  as  both  NKX2.5,  a  cardiac  transcription  factor  (Murry  et  al  2008)  and  the 
neuroepithelial stem cell marker Nestin (Lendahl et al 1990), are both significantly reduced 
upon growth of ES cells on the FIII9-FIII10 dimer when compared to gelatin grown ES 
cells. The reductions in the levels of Nestin are a particular surprise as, in the presence of 
LIF in Foetal calf serum media, the levels of Nestin were elevated when grown on the 
FIII9-FIII10 dimer. It is possible that STAT3 signaling in conjunction with the signals 
received through the interaction of the ES cells with the FIII9-FIII10 dimer result in up 
regulation of Nestin and Nanog, similar to the mechanism which Brachyury and Nanog 
can be up regulated in the presence of LIF (Suzuki et  al a,b 2006). 
 
 
At the time points used in this assay there is no effect on the levels of Flk-1 transcripts by 
growth of ES cells on either gelatin or the FIII9-FIII10 dimer in serum replacement media 
as there is a uniform reduction in the levels of Flk-1 transcripts. It must be concluded 
therefore that in this particular assay there is no stimulus for endothelial differentiaton due 
to  the  reduction  in  Flk-1  transcripts.  In  media  containing  foetal  calf  serum  there  is  a 
transient increase in the levels of Flk-1 as discussed earlier. Again it is possible that the 
foetal calf serum in addition to the FIII9-FIII10 dimer provides an environment that is 
favorable to an increase in Flk-1 transcripts.  
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The levels of CD34 are also unperturbed upon growth of ES cells on either gelatin or the 
FIII9-FIII10 dimer in the serum replacement medium based assay. Also no effect on the 
levels of SCL transcripts were observed when ES cells were grown on gelatin or the FIII9-
FIII10 dimer although there was a substantial reduction in the levels of transcripts when 
compared with undifferentiated controls. It is possible this occurs as growth in the absence 
of LIF on either gelatin or the FIII9-FIII10 dimer is not suitable for the up regulation of 
SCL at the time points tested. This would fit as both SCL and CD34 are hematopoietic 
markers and in this current assay there is little evidence to suggest that the ES cells are 
differentiating along this lineage. 
 
 
To conclude, there is evidence presented in this thesis that indicates that the FIII9-FIII10 
dimer  is  the  most  efficient  of  all  the  conformations  of  the  FIII9-FIII10  derivatives  in 
supporting  ES  cell  growth.  There  are  potential  advantages  in  using  these  FIII9-FIII10 
derivatives in terms of cell attachment over standard fibronectin as there is greater control 
over the purity and structure as discussed in the introduction. In addition these FIII9-FIII10 
proteins  would  be  cheaper  to  manufacture  than  standard  fibronectin.  In  terms  of 
differentiation potential, there appears to be some signs that transcriptionally, the FIII9-
FIII10 dimer has some mesodermal/endodermal effects. However these proteins on their 
own are not adequate to generate specific cell lineages and would be required to be used in 
conjunction with numerous other factors. 
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